C-Z3MEAltoida
neuroscience, machine learning, sensor data
diagnostics
Loading
Loading section...0-100 chain-logic scale · 15 dimensions · scored on public evidence
←All companiesC-Z3ME
C-Z3MEC-Z3MEneuroscience, machine learning, sensor data
0-100 chain-logic scale · 15 dimensions · scored on public evidence
The purpose of this study is to establish multiple points of clinical validity for the Altoida digital biomarker assessment in individuals with a clinical diagnosis of cognitively normal (CN) and Mild Cognitive Impairment (MCI). Participants will use the Altoida app and the de-identified sensor data captured by the device will be used to train specific machine-learning algorithms to recognize early symptoms of cognitive decline, such as MCI or MCI with likelihood of amyloid pathology, as measured by digital biomarkers (T1 - Visit 1). Participants will be invited for an additional visit to evaluate test-retest reliability (T1' - Visit 2). Optionally, an updated variation of the Altoida app will be tested over the course of two additional visits to ensure optimal digital assessment delivery based on best practices in neuropsychological testing, user experience design, and data collection integrity (T2 - Visit 3 and T2' - Visit 4).
Alzheimer's disease (AD) clinically characterized by the cognitive impairment and lowering of various functional abilities lead to staggering costs and suffering, which are particularly related to the social impacts of caring for increasingly disabled individuals. Some of these changes can be almost undetectable in the early stages of the disease, worsening over time often and at a varying rate of progression in different people. The traditional clinical scales or questionnaires such as ADCS (Alzheimer's Disease Cooperative Study) - ADL (Activities of Daily Living) for detecting such functional disabilities are typically blunt and rely on direct observation or caregiver recall. Digital technologies, particularly those based on the use of smart phones, wearable and/or home-based monitoring devices, here defined as 'Remote Measurement Technologies' (RMTs), provide an opportunity to change radically the way in which functional assessment is undertaken in AD, RMTs have potential to obtain better measurements of behavioral and biological parameters associated with individual Activities of Daily Living (ADL) when compared to the current subjective scales or questionnaires. Divergence from normative ADL profiles could objectively indicate the presence of incipient functional impairment at the very early stages of AD. Therefore, the main hypothesis of this study is that RMTs should allow the detection of impairments in functional components of ADLs that occur below the detection threshold of clinical scale or questionnaires.
The proposed study is designed to evaluate the performance of the ALTOIDA™ System as a tool to assist physicians in diagnosing Alzheimer's Disease (AD) in real-world clinical settings. The design of this study is guided by two overriding factors: 1) to optimize the performance of the ALTOIDA™ Neuro Motor Index (NMI) prognosis classifiers, the subjects making up the training sets must be well characterized as to their clinical diagnosis, and 2) all ALTOIDA™ tests must be performed and reproduced in real-world clinical settings. Although there is already a large body of peer-reviewed scientific literature demonstrating that certain digital biomarker patterns are associated with certain neurologic conditions, the utilization of such tools for the evaluation of neurologic disorders is still considered an emerging science and therefore in the investigational stage. Although this protocol will report on brain patterns of certain neurologic conditions such as cognitive impairment and Alzheimer's disease, based on patterns published in peer-reviewed journals, such findings are not considered stand alone or diagnostic per se and should always be considered by the primary physician in conjunction with the patient's clinical condition. These data should only be used as additional information to add to the primary physician's diagnostic impression.
Altoida Advances Alzheimer's Diagnosis with AI and Biomarkers | Marc Jones posted on the topic | LinkedIn LinkedIn respects your privacy LinkedIn and 3rd parties use essential and non-essential cookies to provide, secure, analyze and improve our Services, and to show you relevant ads (including professional and job ads ) on and off LinkedIn. Learn more in our Cookie Policy . Select Accept to consent or Reject to decline non-essential cookies for this use. You can update your choices at any time in your settings . Accept Reject Agree & Join LinkedIn By clicking Continue to join or sign in,
Exploring the Library of Digital Measurement Products – Digital Medicine Society (DiMe) Skip to main content About Us Meet the Team Newsroom Resources in action Sponsors DiMe Project Portfolio Digital Medicine Academy®️ For Individuals For Organizations Get Involved Attend an Event Join an upcoming project Join Team DiMe Read our Blog Spotlight your use of a resource NEW RESOURCE: Digital measures set for common mental health disorders NEW RESOURCE: The sDHT Adoption Navigator for clinical trials NEW RESOURCE: Pediatric rare disease research & care NEW RESOURCE: The Playbook : Implem
tweets | FYRFLY Venture Partners | fyrfly.vc September 21, 2015, 6:40 pm Tweet from IAmAnEdgecase by admin | Sep 21, 2015 | tweets September 21, 2015, 6:40 pmReady to be “disliked”? Facebook throws a negative wrench in the social engagement equation for retailers http://t.co/5o0blhsJc2 @RetailDive September 21, 2015, 5:35 pm Tweet from IAmAnEdgecase by admin | Sep 21, 2015 | tweets September 21, 2015, 5:35 pmPhones drove 94% of YOY incr in traffic, 74% of incr in basket creation & 47% of order growth http://t.co/U9tiRoBslK @FierceRetail @lfheller September 21, 2015, 8:10 pm Twe … t from feedfm by admin | Sep 21, 2015 | tweets September 18, 2015, 7:16 pmA new Rolling Stones album??? Can’t wait! http://t.co/Q45H95BhAw « Older Entries Search for: Recent Posts Borderless Work: How the Co-Founders of Boundless HQ Are Changing the Geography of Employment The Repeat Founders from Rural Switzerland Who Bet on Generative AI Before it was Cool Test Me When I Can: How an Afghan Immigrant and Swedish Engineer are Changing the Future of Exam Proctoring
- YouTube Info Presse Urheberrecht Kontakt Creator Werben Entwickler Impressum Verträge hier kündigen Nutzungsbedingungen Datenschutz Richtlinien & Sicherheit Wie funktioniert YouTube? Neue Funktionen testen © 2026 Google LLC
Checking your browser - reCAPTCHA Checking your browser before accessing pmc.ncbi.nlm.nih.gov ... Click here if you are not automatically redirected after 5 seconds.
Past Conferences | AD/PD™ 2027 Alzheimer's & Parkinson's Diseases Conference Skip to content AD/PD™ 2026 Virtual Login About Welcome Message Your Guide to AD/PD™ 2027 AD/PD™ Committee Past Conferences Partners & Related Events AD/PD™ Education on UNLOK FAQ Press Information Contact us Program Scientific Program Plenary Sessions Speaker Lecture Titles CME-CPD Accreditation Abstracts Abstract Submission Abstract Topics Junior Faculty Awards Instructions for Oral Presenters and Chairs ONSITE Instructions for Oral Presenters VIRTUAL Instructions for Poster Presenters Attend Register Grou … r Supporters and Exhibitors Payment Methods, Terms & Conditions Contact ILS Submit Abstract AD/PD™ 2026 Virtual Login About Welcome Message Your Guide to AD/PD™ 2027 AD/PD™ Committee Past Conferences Partners & Related Events AD/PD™ Education on UNLOK FAQ Press Information Contact us Program Scientific Program Plenary Sessions Speaker Lecture Titles CME-CPD Accreditation Abstracts Abstract Submission Abstract Topics Junior Faculty Awards Instructions for Oral Presen … r Supporters and Exhibitors Payment Methods, Terms & Conditions Contact ILS Submit Abstract AD/PD™ 2026 Virtual Login About Welcome Message Your Guide to AD/PD™ 2027 AD/PD™ Committee Past Conferences Partners & Related Events AD/PD™ Education on UNLOK FAQ Press Information Contact us Program Scientific Program Plenary Sessions Speaker Lecture Titles CME-CPD Accreditation Abstracts Abstract Submission Abstract Topics Junior Faculty Awards Instructions for Oral Presen … ing saliva and skin secretions for telltale signs of Parkinson’s disease. Their prize? A diagnostic test at the pre-motor stage.” ARIAS: Zooming in On Eye-based Biomarkers for Alzheimer’s “Scientists know that the retina changes in people with preclinical AD; alas, there is neither consensus nor convergence in the field of retinal imaging. An upcoming initiative aims to determine which measures are most robust.” On The Docket at AD/PD: The Many Crimes of ApoE4 “Microglia clea … ibe to our newsletter Subscribe to our newsletter to make sure you never miss a deadline and have direct access to all up-to-date materials. About The AD/PD™ Alzheimer’s Disease and Parkinson’s Disease Conference will present all the latest breakthroughs in treatment, translational R&D, early diagnosis, drug development, and clinical trials i
Mission Based Media Launches Alzheimer’s Podcast, the Newest Podcast Miniseries on Health UNMUTED™ HealthPodcast.Org Health Podcast Library Health Podcast Summit Blog Sponsor Integrity Pledge Contact Us Mission Based Media Launches Alzheimer’s Podcast, the Newest Podcast Miniseries on Health UNMUTED™ news June 14, 2022 • 3 min read LONDON, June 14 — / PRNewswire /Mission Based Media, a leader in podcasts about health, care and well-being, has launched a new podcast miniseries about Alzheimer’s disease. The Alzheimer’s Podcast miniseries provides insights and information for those who are diagn
Altoida’s Vision For Alzheimer’s Care Combines Digital Screening, Blood-Based Tests, New Drugs Pink Sheet Scrip Medtech Insight HBW Insight Generics Bulletin In Vivo Spotlight FDA EU Medical Device Regulation Robotics AI Interviews Business Deals Financing Earnings Startups R&D Policy & Regulation Approvals Recalls Legislation Compliance IP & Litigation Commercial Trackers M&A Deals Financing Deals Executive Moves Company Rankings Regulatory Trackers US Original PMAs US PMA Supplements US 510(k) Clearances US De Novo Classifications Non-US Approvals US FDA Warning Letters US Br … st Spotify About About Us Opens in new window Meet the Team Editorial Standards Award-Winning Journalism Help Advertise Opens in new window Contact Us Evaluate Home Account My Account My View Email Preferences Start Free Trial Opens in new window More Medtech Top 100 Ranking Data Trackers FDA Warning Letters Terms and Conditions Opens in new window Privacy Policy Opens in new window
Closing the Gap in Brain Health with Altoida's Digital NeuroMarker Platform | Altoida, Inc. posted on the topic | LinkedIn LinkedIn respects your privacy LinkedIn and 3rd parties use essential and non-essential cookies to provide, secure, analyze and improve our Services, and to show you relevant ads (including professional and job ads ) on and off LinkedIn. Learn more in our Cookie Policy . Select Accept to consent or Reject to decline non-essential cookies for this use. You can update your choices at any time in your settings . Accept Reject Agree & Join LinkedIn By clicking Continue to … s PNI Minute, Michael Yong , MD, MPH, MBA, board-certified Otolaryngologist and fellowship-trained ENT surgeon at Pacific Neuroscience Institute, discusses the relationship between smell and brain health, along with the importance of recognizing symptoms early. As research into neurodegenerative disease continues to evolve, conversations around early detection and patient awareness remain increasingly important. Listen to the full PNI Think Neuro Podcast. #PNI #PacificNeuro #
Altoida's Digital NeuroMarker Platform: Advancing Brain Health with Diversity | Altoida, Inc. posted on the topic | LinkedIn LinkedIn respects your privacy LinkedIn and 3rd parties use essential and non-essential cookies to provide, secure, analyze and improve our Services, and to show you relevant ads (including professional and job ads ) on and off LinkedIn. Learn more in our Cookie Policy . Select Accept to consent or Reject to decline non-essential cookies for this use. You can update your choices at any time in your settings . Accept Reject Agree & Join LinkedIn By clicking Continue t
Detecting cognitive decline early with AI and digital biomarkers | The Health Pulse Episode on Amazon Music Home Home Podcasts Podcasts Library Cancel Sign in Detecting cognitive decline early with AI and digital biomarkers The Health Pulse May 12 2026 • 39 mins Up to 200 million people worldwide may be living with undiagnosed mild cognitive impairment – many unaware that early intervention could change their trajectory. In this episode, host Alex Maiersperger is joined by Marc Jones, CEO of Altoida, and Dr. Mona Flores of Altoida's Clinical Advisory Board to explore how AI and digital biomark
Earlier Detection of Cognitive Disorders Explained Skip to primary navigation Skip to main content Health Connective About Services Custom Marcom Tools Digital Surgery Online Portal Streamline Your Product Ordering Our Work Surgical Case Review Portals Online Product Catalog Account Management Dashboard Surgical Device Certification System Internal Resources Website for Marketing Division Co-Branding Dashboard Physician Locators Resources Marcom Insights Development Insights The Health Connective Show Get Started Schedule a Call with Health Connective Our Capabilities Security & Compliance … t State of Medtech Startups with Alyssa Huffman & Ted Bird January 14, 2025 Application Development for Older Adults with Jennifer Cain Birkmose September 17, 2024 AI’s Role in Proactive Healthcare with Adityo Prakash April 9, 2024 Learn More About the Show Download Transcript In this Episode 00:00 Introduction to Altoida and Neuromarker Platform 02:56 Understanding the Assessment Process 05:48 Comparison with Current Standard of Care 11:48 The Importance of Early Detecti
"Podcast: Marc Jones on early detection and intervention for Alzheimer's" | Michael Roberts posted on the topic | LinkedIn LinkedIn respects your privacy LinkedIn and 3rd parties use essential and non-essential cookies to provide, secure, analyze and improve our Services, and to show you relevant ads (including professional and job ads ) on and off LinkedIn. Learn more in our Cookie Policy . Select Accept to consent or Reject to decline non-essential cookies for this use. You can update your choices at any time in your settings . Accept Reject Agree & Join LinkedIn By clicking Co
Earlier Detection of Cognitive Disorders with Marc Jones of Altoida | Shift Forward Health Search for: Podcasts About Community Books Partners Podcasts About Community Books Partners Earlier Detection of Cognitive Disorders with Marc Jones of Altoida September 16, 2025 Consumer-First Health Group Paradigm Shift of Healthcare 33:05 75.75M Comments Off on Earlier Detection of Cognitive Disorders with Marc Jones of Altoida https://shiftforwardhealth.com/podcast-player/4055/earlier-detection-of-cognitive-disorders-with-marc-jones-of-altoida.mp3 Download file | Play in new window | Duration: 33:05
#alzheimer | Daniella Tinoco, MSc, Ph.D LinkedIn respects your privacy LinkedIn and 3rd parties use essential and non-essential cookies to provide, secure, analyze and improve our Services, and to show you relevant ads (including professional and job ads ) on and off LinkedIn. Learn more in our Cookie Policy . Select Accept to consent or Reject to decline non-essential cookies for this use. You can update your choices at any time in your settings . Accept Reject Agree & Join LinkedIn By clicking Continue to join or sign in, you agree to LinkedIn’s User Agreement , Privacy Policy , and Cookie P … ion in Aging Multiple Sclerosis” has received funding from Stiftelsen Dam! This grant allows us to build on our ongoing work exploring how vascular and demyelinating processes increasingly intersect. By applying advanced MRI techniques, we aim to improve diagnostic precision and help clinicians distinguish between vascular and demyelinating lesions in older individuals with MS. Huge thanks to Stiftelsen Dam and @MS-forbundet for supporting this next step in our research. We’r
Alzheimer's Disease Prediction Service - EIT Health Skip to content --> EIT Health Members Hub News Events Menu Search --> Learn About Us Access Our Programmes Apply For Funding Join Us Learn About Us Who We Are How EIT Health Works Our Achievements External Collaborations Think Tank Annual Reports Programmes Education Programmes All Our Programmes Apply For Funding Open Opportunities Our impact Our Achievements Spotlight Think Tank Our Reports Join Us Become a Member Join the Innovators Community A Framework for Innovation in Healthcare Advisory Boards Annual Report Annual Report –
Ioannis Tarnanas · Founder & Chief Science Officer of Altoida | FYRFLY Venture Partners | fyrfly.vc Ioannis Tarnanas · Founder & Chief Science Officer of Altoida by Lorea Sinclaire | Jan 8, 2021 | founder story | 0 comments Entrepreneurship What is your founder story? What led me to be an entrepreneur is a strong personal need for freedom and living the dream of having a positive impact on others. Altoida, was inspired by my Grandmother, who suffered from Alzheimer’s, and always pushed me forward to enable people to easily assess their brain health and detect neurodegenerative sympto … for mental health, but had to first serve at the Greek military instead! Submit a Comment Cancel reply Your email address will not be published. Required fields are marked * Comment * Name * Email * Website Save my name, email, and website in this browser for the next time I comment. Search for: Recent Posts Borderless Work: How the Co-Founders of Boundless HQ Are Changing the Geography of Employment The Repeat Founders from Rural Switzerland Who Bet on Generative AI B
Additional $14 million for Altoida to advance its neurocognitive assessment platform News Calendar Assets About Us Principal Innosuisse Startupticker Foundation Team Editorial statute Partners & Contributors Supporters Cooperations FAQ Join us Impressum Contact information startupticker.ch Habsburgerstrasse 31 CH-6003 Luzern Tel: +41 41 226 20 80 Fax: +41 41 226 20 89 [email protected] Submit an event Submit special offer Login Register Cancel Forgot password? Login All news Editorial Guest column Startup Media House Get the newsletter Events Trainings Award Deadlines Ecosystem Directory S … ter Register for free to our services and get the newsletter Browse by category Award Background Editorial Expansion Financing Follower Power Guest column Key Partner Launch Partner Post Setback Sponsored Success Support Events Trainings Award deadlines Most viewed events 1 First Swiss Scale-up Report - take part in the survey 2 SHS Webinar "Fuel Your Healthcare Innovation: Unlocking Millions in European Funding" 3 Product Marketing x GTM Meetup in Zurich Submit an … ke-minded people in thestartup community. ecosystem.startupticker.ch Saved news Award Alarms Profile Logout Additional $14 million for Altoida to advance its neurocognitive assessment platform Financing Please login or register 01.04.2022 Led by M Ventures and Whitecap Venture Partners, the additional capital brings Altoida’s series A financing round to $20.3 million. The precision neurology company will use the funds to advance its first in class ai-powered neurocognitive as … er to use the awards follow feature Highlights Altoida AG Top 100 Swiss Startup Award 2017 Top 100 Swiss Startup Award 2018 Top 100 Swiss Startup Award 2019 Top 100 Swiss Startup Award 2020 Top 100 Swiss Startup Award 2021 Related News Altoida AG 04.01.2024 16:00 Altoida’s study unveils encouraging results for Alzheimer’s Disease assessment 25.10.2023 17:00 Positive clinical developments for three digital health startups 12.06.2023 16:32 Key executive hires for seven startups … Register for more services Create your personal archive Get the Newsletter Set award alarms Partners Contributors Supporters Supporters News Startup Media House Pinboard News archive Newsletter archive Editorials Directories Awards Grants & Loans Jobs Investors Facts Initiatives Archive News Interviews Editorials Magazines Swiss Venture Capital
8th Annual Outsourcing in Clinical Trials DACH 2025 - Arena International --> Home About Us Events Contact Us Why attend? 2025 Agenda OCT Advisory Board 2025 Speakers Plan Your Visit Event Gallery 2025 Sponsors Why partner? Contact Us Download Agenda Registration Closed 8th Annual Outsourcing in Clinical Trials DACH 2025 Providing a specific platform for the clinical trials community in the DACH region to develop innovative clinical operations and outsourcing strategies. Start 12 Nov End 13 Nov Kameha Grand Zurich, Autograph Collection Dufaux-Strasse 1 8152 Zürich, Switzer … ntric. Piotr has a track record of scaling enterprise AI strategies and driving award-winning innovation. Recognized for driving digital transformation in pharmaceutical industry, he is passionate about challenging conventions and shaping the future of clinical research. Next speaker Back Amir Ahari Global Head Clinical Studies Neuroscience, Novartis Amir Ahari is a Persian / Swiss national having lived and worked since 1988 in Germany and Switzerland. He gained his mechanic … f Global Clinical Operations, Team Leader, Roche 1 PM Lunch and networking with Prize Draw at 14:15 2:30 PM Accelerating study start-up: breaking bottlenecks and enhancing predictability Strategic initial planning and ensuring predictability Engagement with vendors, sites, internal and external stakeholders Breaking critical pathway and identifying bottlenecks Sharing practical tips and best practices for smoother execution Speakers Rachel Yicen Xu University of Zurich & Form … Prism project, which focuses on closing care gaps in IBD through the innovative application of intestinal ultrasound, as well as the #Uninhibited Summit, which brings together and supports communities of shared interest. Additionally, she oversaw the pilot and rollout of forpatients.roche.com, a website designed for patients and caregivers that offers clinical study information in accessible language. Earlier in her career, Maria managed early phase clinical studies at Quinti … Switzerland in 2019. Dr. Chadha is also a recipient of the World Sustainability Award for advancing precision medicine, and the “Premio Medicina Italia” for her leadership during the pandemic. In 2022, she received the Veuve Clicquot Bold Woman Award in Switzerland. Most recently, in 2024, she was honored with the “Women Empowering Award” and rec
Checking your browser - reCAPTCHA Checking your browser before accessing pmc.ncbi.nlm.nih.gov ... Click here if you are not automatically redirected after 5 seconds.
👩⚕️ Gaps in your clinical... - Instituto Pedro Nunes Facebook Log In Instituto Pedro Nunes's Post Instituto Pedro Nunes 1d · Shared with Public Gaps in your clinical evidence can completely stall your market launch. Don't let that happen. Join our clinical expert, Inês Urbano, for the 4th session of the IPN HealthProof Webinar Series: Clinical Evaluation Unlocked: Clear Answers to Common Struggles, in partnership with DigiHealthPT. Get direct insights into creating compliant literature reviews, demonstrating equivalence, and building a bulletproof CER that auditors will trust. 30 J
Altoida upsizes its Series A Round to $20.3M to Advance Its First in Class AI-Powered Neurocognitive Assessment Platform - M Ventures Zum Inhalt springen Wegweiser About Us Portfolio Team Career News Contact Zur Startseite wechseln Altoida upsizes its Series A Round to $20.3M to Advance Its First in Class AI-Powered Neurocognitive Assessment Platform 2022/03/30 Altoida, Inc. raised an additional $14 million for its Series A round with new and existing investors. The investment was co-led by M Ventures and Whitecap Venture Partners Altoida, Inc., the precision neurology company pioneering non-i
Transforming Women’s Health through Science and Sustainable Partnerships - Society for Women's Health Research About Staff Board of Directors Clinical Advisory Board Newsroom Job Opportunities The Role of Women’s Health Research Timeline SWHR Celebrates 35 Years Programs Health Focus Areas Alopecia Areata Alzheimer’s Disease Atopic Dermatitis Autoimmune Diseases Bone Health Clinical Trials Diagnostics Endometriosis Expanded Carrier Screening Eye Health Fertility Heart Health HPV & Related Diseases Liver Health Lupus Maternal and Infant Health Disparities Menopause Midlife Health Migr … and cancer received the Royal College of Physicians Excellence in Patient Care Award and the prestigious European Communique Award. His team won the HDR-UK Impact of the Year Award for providing the crucial intelligence informing a change in policy for treating colorectal cancer. He led the Lancet Oncology European Groundshot Commission, the most comprehensive analysis of cancer research in Europe. His recent landmark study highlighted the significant gender inequity in seni … isiana State University Health Sciences Center in New Orleans and completed her residency at the University of Texas Southwestern/Parkland Memorial Hospital in Dallas. She is board-certified by the American College of Obstetrics and Gynecology. With years of experience in private practice, Dr. Pero specializes in Obstetrics, Gynecology, and Infertility, providing care to thousands of women and supporting families through high-risk pregnancies. She is a Diplomate and Fellow of … erland, and has received numerous accolades, including the World Sustainability Award, the Veuve Clicquot Bold Woman Award, and the Women Empowering Award. In addition to these, in 2024 she was honoured with the “Katherinenturm” Project for her scientific contributions in Switzerland. H.E. Oluwatoyin Ojora Saraki, LLB, LLM, BL, FPH Founder & President, Wellbeing Foundation Africa H.E. Oluwatoyin Ojora Saraki, LLB, LLM, BL, FPH Founder & President, Wellbeing Foundation
Altoida, Inc. | FYRFLY Venture Partners Job Board About Portfolio Careers Pledge 1% Contact Us Careers Search jobs Explore companies Join talent network Talent My job alerts Altoida, Inc. altoida.com Locations Suwanee, GA, USA · Washington, DC, USA · Washington, DC, USA · lucerne, switzerland · Connecticut Ave/ K Street, Washington, DC, USA · Fort Stanton, Washington, DC, USA · Columbia Heights, Washington, DC, USA founded in 2016 Socials LinkedIn Crunchbase Twitter Facebook About Altoida is creating a new gold standard in brain health with Precision Neurology. We're radically transformin
Duelbits Free Spins Offers In The United Kingdom - Altoida Home About Leadership Science Publications Partnerships Media News Press Releases Our Videos Careers Contact Duelbits Free Spins Offers In The United Kingdom June 24, 2026 | adminalt Unlocking Free Spin Opportunities at Duelbits UK For players in the United Kingdom, navigating the world of online casinos to find valuable promotions can be a detailed task, but Duelbits has streamlined the experience with a range of compelling free spin offers. These promotions are a significant draw for both new and seasoned players, providing ext … n to get started. Make a Deposit: To participate in the promotions, you need to fund your account. Duelbits supports a variety of payment methods, including traditional options and popular cryptocurrencies. Meet Wagering Milestones: The Rookie Rush offer is tied to wagering. As you play selected games and reach predetermined wagering amounts, free spins are automatically credited to your account. Use Your Free Spins: Once awarded, the free spins can be used on a selection of … r existing players, Duelbits frequently runs reload bonuses. These offers might grant a batch of free spins when you make a new deposit, often tied to specific days of the week or special events. Loyalty Rewards: The "Ace's Rewards" programme is the cornerstone of player retention. This VIP and rakeback scheme returns a percentage of the house edge to players. While often paid in "Bits" (the platform's currency), these rewards can be used to play more games, effectively creat … p to 117,649 ways to win. Jackpot Slots Mega Moolah, Divine Fortune Progressive prize pools that can reach life-changing sums. Duelbits Originals Crash, Dice, Plinko Provably fair games exclusive to the platform. The variety ensures that players with different tastes can find something to enjoy. Using free spins on these games is an excellent way to experience their mechanics and features without any risk to your own balance. Payment Methods for UK Players To claim any deposi … sit-related free spin offers at Duelbits, players in the United Kingdom need to fund their accounts. The casino accommodates a modern audience by offering a blend of traditional fiat currency methods and a wide array of cryptocurrencies. This flexibility is a major advantage, allowing for fast and secure transactions. Here is a summary of the pay
Speaker Biographies | Integrative Healthcare Symposium Skip to content February 18-20, 2027 • Hilton Midtown • New York, NY Attend Networking Venue & Hotel Sponsored Education Product Showcase Exhibit Hall Floorplan Conference 2026 Agenda 2026 Speakers Download Brochure & Event Guide 2026 Continuing Education Credits 2027 Advisory Board Exhibit Exhibit Services Why Exhibit? Sponsorship Opportunities Official Vendors Product Showcase Exhibit Hall Floorplan Sponsor/Exhibitor 2027 Re-Sign About About the Symposium Official Media News Press Registration Send Me Up
Slotexo Mobile Casino Australia: App And Browser Performance - Altoida Home About Leadership Science Publications Partnerships Media News Press Releases Our Videos Careers Contact Slotexo Mobile Casino Australia: App And Browser Performance June 24, 2026 | adminalt Exploring The Slotexo Mobile Casino Experience In Australia In an era where gaming on the go is not just a luxury but an expectation, Australian players are increasingly turning to mobile platforms for their casino entertainment. Slotexo has emerged as a significant player in this space, offering a comprehensive mobile experie … s both fast and reliable. Whether accessed through a web browser or a dedicated application, the user experience is designed to be intuitive and fluid. The interface is optimised for smaller screens, with large, easy-to-tap buttons and menus that are simple to navigate. This focus on user-centric design means less time spent figuring out controls and more time enjoying the vast selection of pokies and table games. The platform’s stability ensures that gameplay is rarely inter … ly experiences, some players still prefer the convenience of a dedicated mobile application. At present, Slotexo primarily focuses on delivering a superior browser-based platform, which functions as a Progressive Web App (PWA). This means that while there may not be a traditional app to download from the Google Play or Apple App Store, players can add a shortcut to the Slotexo website directly to their home screen. This shortcut functions much like a native app, providing ins … imes and a stable interface, while avoiding the storage consumption of a native application. For Android users, the experience is particularly seamless, as Chrome's "Add to Home Screen" feature creates an icon that launches the site in a dedicated window without the browser's address bar, further enhancing the native-app feel. iOS users can achieve a similar result using Safari's "Add to Home Screen" option. This modern solution combines the best of both worlds: the accessibi
Altoida Careers, Perks + Culture | Built In Companies Jobs Articles Can't find your company? Create a company profile. View All Jobs Join Log In For Employers Companies Altoida Teams Altoida Save Saved HQ Washington 41 Total Employees Year Founded: 2016 View Website Overview Jobs 1 Offices Is This Your Company? Manage Jobs Healthtech Altoida Medical Device (AMD) provides health care professionals objective measurements of cognitive performance. Recently Posted Jobs at Altoida View All Altoida Open Application Remote USA View all jobs Altoida Offices OnSite Workspace Employees work from ph
Jan 27-29, 90+ Exhibitors at PMWC 2027 Silicon Valley Chat with us , powered by LiveChat Skip to content Chats Contact Speakers Agenda Tickets Menu FULL MENU FULL MENU Register here Rates by JUL. 2 Register here PMWC, Jan 25-27, 2023 PMWC - Silicon valley, ca January 27-29, 2027 Past Event PMWC, Feb 5-7, 2025 PMWC - Silicon valley, ca January 27-29, 2027 Attend Program Schedule Sessions Honorees Speakers Company Competition Showcases Travel Venue Sightseeing Reduced Rates Hotel Flights Exhibits + Map Login / My Account Participate REGISTER TO EXHIBIT Prospectus Attendee Breakdown Apply to spea … ogin / My Account Participate Register to Exhibit Prospectus Attendee Breakdown Apply to speak Sponsorship Inquiry GET UPDATES ABOUT Mission Testimonial Past Conferences Past Honorees Past Speakers FAQ CONTACT US Menu agenda speakers exhibits Contact us agenda speakers exhibits Contact us BUY TICKETS SAVE $1351 BY JUL. 2 Menu Item #1 Item #1 PMWC - Silicon valley, ca Jan. 27-29, 2027 Pittsburgh, pa sep. 23-24 PMWC - Silicon valley, ca Jan. 27-29, 2027 Register Here Rates by J … tend Program Speakers Travel Exhibits + Map Main Program View your save program Award Reception Speaker gallery Select part speakers Exhibit gallery Part conferences Participate Register to Exhibit Apply to speak Sponsorship Inquiry ABOUT Login / My Account CONTACT US Get Updates Pittsburgh, pa sep. 23-24 Register Here Rates by Attend Program Travel Reduced Rates Exhibits + Map Main Program View your save program Award Reception Paticipate Register to Exibit Apply to speak Sp … nomix Labs Alphaexpeditions Alpine Alquest Therapeutics ALS Emergency Treatment Fund Alta Bates Summit Comprehensive Cancer Center Alta Devices AltaQ Altered Egos Comics AltheaDx Althia Altiora Altis Biosystems, LLC Altoida Inc Altos Labs AltruBio Altum Medical Alum Alumot – sprint Aluna Health Alva10 Alveo Technologies Alverno Laboratories AlwaysRx Alykomed Global Solutions LLC Alykomedglobal Alzheimer’s X Alzheon AMA Ama-Assn Amaro Therapeutics Amazon Amber Health Amb … Y Ancestry Anderson Cancer Center Andreessen Horowitz Andrew Andy Strouse Angel Fund Angel Investor ANGLE Biosciences ANGLE Europe Ltd. ANGLE, plc Angleplc Angstrom Bio Angular Medicine Anima AnjaGen Consulting Anl Annai Systems, Inc Annexon Biosciences Annexon Inc Annexonbio Anocca Ansun Biopharma Antenna Anthem Anthony Pastena, M.D. ,P.C Anthos
%PDF-1.6 %���� 177 0 obj > endobj 209 0 obj >/Filter/FlateDecode/ID[ ]/Index[177 55]/Info 176 0 R/Length 141/Prev 319180/Root 178 0 R/Size 232/Type/XRef/W[1 3 1]>>stream h�bbd```b``.���`�"�d; "�N�e�� �e�d� &���0��=V�," "]��f��Is�i% �� X���)X��T���ER�lA ɘ���_" �A" >�9= L@_8��d` �?S���|� endstream endobj startxref 0 %%EOF 231 0 obj >stream h�b```f``Z������ ĀB@16� ��$ ��,�j�� X �z�/r�|���p�XXl�H�d��6�; �ױ�䮈� c1T���(z;��j`:P_zyyMp)/��r�8�5 p�� >/Metadata 19 0 R/PageLayout/OneColumn/Pages 175 0 R/StructTreeRoot 76 0 R/Type/Catalog>> endobj 179 0 obj >/ExtGState … 17ebc7b-2a2d-41f6-aa73-2c4bf17e21e1 uuid:fff76ebc-bca2-4251-9d3b-c94d465e7590 2 application/pdf Title Subtitle Tom Popper Adobe PDF Library 19.8.103 D:20181005181856 Subtitle endstream endobj 20 0 obj >stream h�247U0P���w�/�+Q0���L)�64��)�I0i"c�C* R��S��� ��� endstream endobj 21 0 obj >stream h�l�AK�@���K�;[I�H)�-,x�d�u�d�t���;�"=xy�cx|�j���ވ��:U�0 ����'-H]�}������ѧH}%;]ݯ�� �.�X�z��]��l��T]= ��r�:�W�`�N_���y& ��]�箙��ʶ ��Vϱaϓ�W�����/4r�⊧��F&�g��;�IK
Augnition Labs | MTEC MTEC Focus Areas Who we serve Solicitations Patents About Us Explore Join MTEC Log In Life Sciences / Companies Augnition Labs Augnition Labs develops AI-enabled digital assessment and monitoring solutions for early detection of cognitive decline. Founded in 2020 on >15 years of neuroscience research, the company builds digital cognitive tests that target pattern separation and works with academic partners and healthcare settings to validate and deploy prescription-use cognitive assessment tools. Industries artificial-intelligence health-diagnostics neuroscience-e37a N … ation with large-scale research networks Human-centered clinical product design Grant-funded clinical R&D Show More (5) Show less Key Technologies Digital cognitive testing Pattern separation-targeted tasks AI and machine learning Cloud-based assessment platform Digital biomarker extraction Integration with population-scale research data Clinical validation workflows Show More (3) Show less News & Updates Participation at International Conference on Learning and Memor … collect population-scale cognition and biomarker data. Awarded Fast-Track SBIR grant from the National Institute on Aging Received a Small Business Innovation Research grant to develop and scale the company's cognitive assessment platform. FDA classification as a prescription-use cognitive assessment aid Regulatory milestone classifying the assessment platform as a Prescription Use Cognitive Assessment Aid (PTY) enabling clinical deployment. Similar organizations Browse
Rollbit Sign Up And Login Steps For United Kingdom Players - Altoida Home About Leadership Science Publications Partnerships Media News Press Releases Our Videos Careers Contact Rollbit Sign Up And Login Steps For United Kingdom Players June 24, 2026 | adminalt Getting Started with Rollbit in the United Kingdom For players in the United Kingdom seeking a comprehensive and secure online gaming experience, understanding the registration and login process is the first step. The platform at Rollbit https://rollbit.org.uk offers a streamlined approach for new users, ensuring that you can move … may be initiated automatically upon registration or may require you to manually submit documents. The types of documents you may be asked to provide are standard across the industry. Document Type Examples Proof of Identity Passport, Driving Licence, National ID Card Proof of Address Utility Bill (e.g., electricity, water, council tax), Bank Statement (dated within the last 3 months) Proof of Payment Photo of your debit card (with middle digits covered), Screenshot of your e-
NeuroEM CEO Chuck Papageorgiou at Neuro Tech Forum | NeuroEM posted on the topic | LinkedIn LinkedIn respects your privacy LinkedIn and 3rd parties use essential and non-essential cookies to provide, secure, analyze and improve our Services, and to show you relevant ads (including professional and job ads ) on and off LinkedIn. Learn more in our Cookie Policy . Select Accept to consent or Reject to decline non-essential cookies for this use. You can update your choices at any time in your settings . Accept Reject Agree & Join LinkedIn By clicking Continue to join or sign in, you agree to Linke … $100M for Alzheimer’s research: The OpenAI Foundation announced a $100 million grant for Alzheimer’s research earlier this week, in partnership with two Bay Area-based research institutes. http://dlvr.it/TS12mX #AlzheimersResearch #OpenAI #HealthcareInnovation #MedicalResearch #FoundationSupport Like Comment Share Copy LinkedIn Facebook X To view or add a comment, sign in Altrovia 484 followers 2mo Edited Report this post A few weeks ago, our partners at BiHELab Ionian Unive
Altoida, Inc. | b2venture Job Board Home Companies Stories Team About Contact Startup Resources Startup Resources Home Companies Stories Team About Contact Join the b2venture community at one of our portfolio companies. See all open positions below. Interested in working directly for b2venture? Learn more. Search jobs Explore companies Join talent network Talent My job alerts Altoida, Inc. altoida.com Locations Suwanee, GA, USA · Washington, DC, USA · Washington, DC, USA · lucerne, switzerland · Connecticut Ave/ K Street, Washington, DC, USA · Fort Stanton, Washington, DC, USA · Columbia Heigh
Betwright Casino Free Spins Offers For United Kingdom Players - Altoida Home About Leadership Science Publications Partnerships Media News Press Releases Our Videos Careers Contact Betwright Casino Free Spins Offers For United Kingdom Players June 24, 2026 | adminalt Unlock Free Spins and Exciting Gameplay at Betwright Casino For online slot enthusiasts in the United Kingdom, free spins offers are a prime attraction, providing a chance to explore new games and win real money without risking their own funds. Betwright Casino has emerged as a noteworthy destination for players seeking thes … ffers available, how to claim them, and the important terms and conditions that apply. Welcome Bonus: Your First Taste of Free Spins The journey at Betwright Casino for new players from the United Kingdom begins with an enticing welcome offer. Typically, this initial bonus is designed to give newcomers a significant advantage, and free spins are often the main event. Upon making a qualifying first deposit, players can unlock a set number of free spins on a pre-selected, popul
Technical Support Lead @ Altoida, Inc. | FYRFLY Venture Partners Job Board About Portfolio Careers Pledge 1% Contact Us Careers Search jobs Explore companies Join talent network Talent My job alerts Technical Support Lead Altoida, Inc. This job is no longer accepting applications See open jobs at Altoida, Inc. . See open jobs similar to " Technical Support Lead " FYRFLY Venture Partners . IT, Customer Service United States · Massachusetts, USA · Boston, MA, USA Posted 6+ months ago Altoida is a pioneer in developing digital biomarkers of neurological disease using augmented reality a … all team members. Work as a team member to provide direct support for product, application, and performance questions received from direct customers and internal Altoida employees. Formally manage the Complaint process to ensure we are compliant with regulations and addressing customer concerns Consistently guide the team to prompt issue resolution and continuously demonstrate professionalism while maintaining a keen sense of quality and the customer experience. Oversee the … w releases Collaborate with the Product & Engineering teams on user issues, application bugs, and enhancement requests Participate in service improvement projects and initiatives, including providing guidance on the application and processes developed at Altoida that directly affect customers. Develop an understanding of the needs of customers, study teams, sites and trial participants, as well as internal cross-functional teams at Altoida Desired Skills & Experience
BIO Partnering @ JPM Week 2026 | Participating Companies Skip To Main Content Home Partnering Show submenu for: Partnering BIO Partnering™ Participating Companies Participating Investors BIO Partnering Mobile App LOG IN TO BIO PARTNERING Webinars Show submenu for: Webinars Investor & Exec Panel Partnering Tips and Tricks Plan Show submenu for: Plan Social Media Toolkit BIO Partnering Mobile App JPM Events Guide App FAQs Sponsor More Show more menu items January 12-15 | San Francisco Marriott Marquis January 12-16 | Virtual Home Partnering Show submenu for: Partnering BIO Partnering™ Parti … 20n Bio 28 Capital 28bio 2Flo Ventures 3D BioFibR Inc. 3Helix 3i Corporation 3i Fund 3i Partners 3S Bio Pharmaceutical Group 5Y Capital 6 Dimensions Capital 7 Hills Pharma, Inc. 7G BioVentures 88Helix Ventures A&J Science Co., Ltd. AAA Family Office Aavnergene Inc. AB Family Office AB Science AbbVie Contract Manufacturing Ability Biotherapeutics Ability Pharmaceuticals ABION Inc. Able Tx Ablexis, LLC Absci Absco Therapeutics AbTherx AbVir Biotherapeutics ACADIA Pharmaceut … Therapeutics, Inc. AcuraStem Inc. Acurex Biosciences Corporation ADA Innovation Fund Adelphi Ventures_Jae Won Kim Adial Pharmaceuticals Adimab, LLC Adipo Therapeutics, LLC AdipoSeeds Inc. Adiso Therapeutics Aditum Bio Adjuvant Capital ADM Healthcare AdvanCell Pty Ltd Advantary Capital Partners Adze Biotechnology Inc Aegis Capital Corp. Affinity Biopharmaceutical Co., Ltd. age1 Agilex Biolabs AIAC Group (SFO)_Robert Colorina AIcloud Ailux Aimed Bio, Inc. Ainnocence AION Labs A
Beginner Tips For Choosing Casino Games On Goldbet - Altoida Home About Leadership Science Publications Partnerships Media News Press Releases Our Videos Careers Contact Beginner Tips For Choosing Casino Games On Goldbet June 24, 2026 | adminalt Navigating the World of Goldbet Casino Games Starting your journey at an online casino can be both exciting and a little overwhelming, especially with the vast selection of games available. For new players in the United Kingdom, Goldbet offers a diverse portfolio that caters to every taste and skill level. This guide provides essential tips for b … ames. These games often have a lower house edge than slots, especially when you apply a basic strategy. Blackjack is a great starting point because the goal is simple: get a hand value closer to 21 than the dealer without going over. Basic strategy charts are widely available online and can significantly improve your chances of winning. Roulette is another classic that is based more on luck but still offers strategic betting options. You can place simple bets on red or black,
Marc Jones, Altoida - Neurological Assessment Using AI And AR | LSI Europe '25 - Life Science Intelligence USA Europe Asia Compass AI Login Medtech Pro Login Events Featured Our Next Event Register for LSI Asia ‘26 Who's Attending? See LSI Asia '26 Attendee List Events Overview See Who's Attending Who Attends Why Present Upcoming Summits LSI Asia ‘26 LSI Europe '26 LSI USA ‘27 Past Summits LSI Asia ‘25 LSI Europe ‘25 LSI USA ‘26 Archives Insights Featured Just Launched Compass AI New Report Emerging Innovators Report Compass Al Emerging Innovators Report Market Data Custom Research Magazi … 39;s gumming up the referral networks. So Altoida has developed a tablet- based application that's multimodal. So, as I mentioned, speech language, u we're using um t tapping and drawing and augmented reality where we're actually in our space moving around to detect the ability um to understand both in the cognitive subdomains and domains where people's um dysfunction is emanating from. And this is huge and we've utilized this across the globe uh in h … 39;s gumming up the referral networks. So Altoida has developed a tablet- based application that's multimodal. So, as I mentioned, speech language, u we're using um t tapping and drawing and augmented reality where we're actually in our space moving around to detect the ability um to understand both in the cognitive subdomains and domains where people's um dysfunction is emanating from. And this is huge and we've utilized this across the globe uh in h
%PDF-1.7 %���� 1302 0 obj > endobj 1322 0 obj >/Filter/FlateDecode/ID[ ]/Index[1302 51]/Info 1301 0 R/Length 95/Prev 661477/Root 1303 0 R/Size 1353/Type/XRef/W[1 2 1]>>stream h�bbd``b`�$? �/@�� �J�7��� !� $x ��Y�X� %�@�!Hp��1���v�X >stream h�b``�d``������T� ̀�@16����PՕԷ�76z�t� >>>/Lang(en-US)/MarkInfo >/Metadata 104 0 R/PageLabels 1298 0 R/Pages 1300 0 R/StructTreeRoot 203 0 R/Type/Catalog/ViewerPreferences >>> endobj 1304 0 obj >/Font >/ProcSet[/PDF/Text/ImageC]/XObject >>>/Rotate 0/StructParents 0/TrimBox[0.0 0.0 612.0 792.0]/Type/Page>> endobj 1305 0 obj >stream hW{S�8�� � … ��C8-��#V�� +Ё��r1A 6��;���0�� ��|�1vG|U��%�1�'�}�3�)��ˮS+�e�� ŋ�1��;�y�l��Rfp�P��ږ9 �lt� bc��I����.�>��KmU:�8p�������z��;b���@ v��q��A4;�� P�x�^�ޙ1*OPPqK���-Ѷ5����O;k.�5�VbzE�`���m��pc9�OK����X�[����蠫��~�$U�-p�A�C'�c&��Hu*� �C���w��"8� ]�u )��I�#sXCe?K| cء �4��'��h ��RF�W�h� IQ�N��� @(2��9�e��� t�%�̈́�J��등�u�of㺂��ʀ�勋�y�\�L`��>T�Ī�ARV��5�-T��)�\�C࢟]uv�}������7���`P�!G�xڑ).N����mh( $k*'���q�lO,˄S/��횙)pe�j�u[q�Y���2��� 4>MZR�Mb��{��܇� ���Đ … 303286afeb5 xmp.did:702d4e5e-4166-4f9a-a62b-a8877a877e2d default converted from application/x-indesign to application/pdf Adobe InDesign CC 13.1 (Macintosh) / 2019-10-24T17:55:36-05:00 application/pdf Adobe PDF Library 15.0 False endstream endobj 105 0 obj >stream h�2460P0P���w�/�+Q0���L)�6460 )�I# 0el�L���)����,H�HLO-��0�t� endstream endobj 106 0 obj >stream h�d�A �0��n�C�=m�!B8� �CG/�=j�L;��;Dt���@���md����8�� �"��T*U v��D|T��Ɇ���5���m���`L{3;���> !�`���b�ϙ�ߠ
In this Brain TIME series session, sponsored by Eli Lilly and Company, Adam Rosenberg, PhD, highlights new and upcoming radiotracers for imaging Alzheimer’s disease and related dementias. https://youtu.be/ClfOVIP-VWc | Society of Nuclear Medicine and Molecular Imaging
Travis Bond, Altoida - Studio Interview | LSI Europe ‘22 - Life Science Intelligence USA Europe Asia Compass AI Login Medtech Pro Login Events Featured Our Next Event Register for LSI Asia ‘26 Who's Attending? See LSI Asia '26 Attendee List Events Overview See Who's Attending Who Attends Why Present Upcoming Summits LSI Asia ‘26 LSI Europe '26 LSI USA ‘27 Past Summits LSI Asia ‘25 LSI Europe ‘25 LSI USA ‘26 Archives Insights Featured Just Launched Compass AI New Report Emerging Innovators Report Compass Al Emerging Innovators Report Market Data Custom Research Magazine Featured May Edition Exp
Excited for the announcement of the... - Frontiers Health Facebook Log In Frontiers Health's Post Frontiers Health February 28, 2022 · Shared with Public Excited for the announcement of the partnership between our ecosystem friends at Altoida, Inc. and Click Therapeutics, Inc. to power clinical trials for digital therapeutics https://www.businesswire.com/.../Altoida-Announces... . Both companies have been actively involved in our conferences over the years, always committed to leverage their expertise to improve patients' outcomes. Healthware Group Digital Health Global Like Comment
You need to enable JavaScript to run this app. Loading...
Speakers & Panelists | Innovation Summit Dublin 2025 — MedTech Strategist Publications Our Publications MedTech Strategist Market Pathways MyStrategist.com Our Coverage Contributor Guidelines Testimonials Advertise Community Blog Conferences Our Conferences Dublin 2026 San Diego 2026 Past Conferences CEO Conferences Testimonials Events Partner Events MTS Events Past Events Podcast About About Us Contact FAQs Read Now Publications Our Publications MedTech Strategist Market Pathways MyStrategist.com Our Coverage Contributor Guidelines Testimonials Advertise Community Blog Conferences O … signation for their innovative neural platform and delivered the world's firsts application of a graphene-based neural interface in humans. The company also won the Most Innovative Company of the Year in 2022 and the Norrsken IMPACT 100 award in 2024 Jeanne Bolger Venture Partner Seroba Jeanne has over 35 years of pharmaceutical industry experience in management roles across R&D, Commercial and Business Development (BD) and Venture Investments. She spent 11 years in … (2012-2022) as Vice President Venture Investment in J&J’s corporate venture fund, Johnson & Johnson Innovation – JJDC. During that period, she was based in London, leading investments across Europe in start-up and early stage life science companies in areas of strategic interest to J&J’s business sectors in Pharmaceuticals and Biotechnology, Medical Devices and Consumer. She represented JJDC on the Board of Directors of over a dozen companies, including Aeli … Critical Care. James is board-certified in emergency medicine and completed his residency at Massachusetts General Hospital and Brigham and Women’s Hospital. He earned his MD from the Harvard–MIT Program in Health Sciences and Technology (HST), his MBA from the University of Texas McCombs School of Business and his BS in bioengineering from the University of Michigan. Pedro Eerdmans Director, Global Strategy Services NAMSA Dr. Pedro Eerdmans has more than 25 years of experien … dical Director he was responsible for the evaluation of the medical evidence to grant CE certification. He also managed global clinical teams while based in Europe and the U.S. (Houston, Texas). Under his supervision, several medical devices received CE mark, most recently 3 Investigational Device Exemption (IDE) approvals were granted.
Dr. Antonella Santuccione, Altoida - Studio Interview | LSI Europe ‘22 - Life Science Intelligence USA Europe Asia Compass AI Login Medtech Pro Login Events Featured Our Next Event Register for LSI Asia ‘26 Who's Attending? See LSI Asia '26 Attendee List Events Overview See Who's Attending Who Attends Why Present Upcoming Summits LSI Asia ‘26 LSI Europe '26 LSI USA ‘27 Past Summits LSI Asia ‘25 LSI Europe ‘25 LSI USA ‘26 Archives Insights Featured Just Launched Compass AI New Report Emerging Innovators Report Compass Al Emerging Innovators Report Market Data Custom Research Magazine Featured M
Videos | Altoida Home About Leadership Science Publications Partnerships Media News Press Releases Our Videos Careers Contact Altoida Videos Discover Altoida’s latest conversations and milestones shaping the future of precision neurology. Contact Us 80 M Street SE, Suite 100 Washington, DC 20003 USA CONTACT US Follow Us Privacy Policy By visiting our Website and/or using the Services in any manner, you acknowledge that you accept the practices and policies outlined in our Privacy Policy. Certifications Altoida is SOC 2 Type II and ISO 27001 compliant. Copyright © Altoida 2025
Altoida Receives Investment from Alzheimer's Drug Discovery Foundation's Diagnostics Accelerator to Advance Precision Neurology Accessibility Statement Skip Navigation Why PRWeb How It Works Who Uses It Pricing Login GDPR Create a Free Account News Resources Contact Search Search When typing in this field, a list of search results will appear and be automatically updated as you type. Searching for your content... No results found. Please change your search terms and try again. News in Focus Browse News Releases All News Releases Multimedia Gallery All Multimedia All Photos All Videos Business … gh the generosity of its donors, the ADDF has awarded more than $168 million to fund over 650 Alzheimer's drug discovery and biomarker programs and clinical trials in 19 countries. To learn more, please visit: http://www.alzdiscovery.org/ . Media Contact Henry Peck , Altoida, Inc., +1 (240) 720-7538, [email protected] SOURCE Altoida, Inc. Related Links http://www.altoida.com × Modal title Contact PRWeb 11AM ET Sunday – 8PM ET Friday Contact Us Contact Us --> About … a Free Account Log in Contact Us Do not sell or share my personal information: Submit via [email protected] Call Privacy toll-free: 877-297-8921 Contact Cision Products About My Services All News Releases Online Member Center ProfNet Cision Distribution Helpline 888-776-0942 Legal Site Map RSS Cookie Settings Copyright © 2025 Cision US Inc. --> -->
%PDF-1.7 %���� 1366 0 obj > endobj xref 1366 46 0000000016 00000 n 0000002925 00000 n 0000003097 00000 n 0000003135 00000 n 0000004348 00000 n 0000004516 00000 n 0000004748 00000 n 0000005042 00000 n 0000006252 00000 n 0000006291 00000 n 0000006415 00000 n 0000006530 00000 n 0000006788 00000 n 0000007236 00000 n 0000007324 00000 n 0000007443 00000 n 0000011013 00000 n 0000013691 00000 n 0000017001 00000 n 0000019727 00000 n 0000022220 00000 n 0000025225 00000 n 0000025923 00000 n 0000026560 00000 n 0000027174 00000 n 0000027288 00000 n 0000027401 00000 n 0000027949 00000 n 0000028500 00000 n 0 … nJ�8��Ja^NX 3a(�0�K�ю��K�r.B3��a~,� �%KJl��-Iۘ����� g��SP��|e 1 �� >stream application/pdf e74e1ff3-b52f-4a6d-831b-fdc46fbac425 Adobe Illustrator 27.0 (Macintosh) 2022-11-07T16:32:03-05:00 2022-11-07T16:32:03-05:00 2022-11-07T16:32:03-05:00 proof:pdf uuid:65E6390686CF11DBA6E2D887CEACB407 xmp.did:f1cee0fc-fdf1-44c6-b699-76b3dca1e609 uuid:0f2dcfbf-c2f9-2b45-ab94-c85c29d723fc uuid:27f584af-a488-9349-a64a-b29a9af20ed9 xmp.did:8d08eb9c-7571-4e78-aade-d88bdc677e5e uuid:65E6390 … DF library 16.07 21.0.0 endstream endobj 1402 0 obj > endobj 1403 0 obj >stream application/pdf d0a4878f-67e5-455c-b322-f019b69f73ee 2020-02-26T15:58:59-05:00 2020-02-26T15:58:59-05:00 2020-02-26T15:58:59-05:00 Adobe Illustrator 24.0 (Macintosh) uuid:62d2361c-660f-c046-8acc-8e37de6758e5 xmp.did:0edbdb96-3a32-494f-a726-05e3a1c03ef7 uuid:5D20892493BFDB11914A8590D31508C8 proof:pdf uuid:d1c078a0-2746-42b2-b0d1-25aedff8fb1e xmp.did:1b6690ed-28a8-c141-9479-b6a9cf6be651 uuid:5D20892 … 479-b6a9cf6be651 uuid:5D20892493BFDB11914A8590D31508C8 proof:pdf converted from application/pdf to <unknown> saved xmp.iid:D27F11740720681191099C3B601C4548 2008-04-17T14:19:15+05:30 Adobe Illustrator CS4 / converted from application/pdf to <unknown> converted from application/pdf to <unknown> saved xmp.iid:F97F1174072068118D4ED246B3ADB1C6 2008-05-15T16:23:06-07:00 Adobe Illustrator CS4 / saved xmp.iid:FA7F1174072068118D4ED246B3ADB1C6 2008-05-15T17:10:45-07:0 … DDFD38D0CF24DD 2008-05-16T10:35:43-07:00 Adobe Illustrator CS4 / converted from application/pdf to <unknown> saved xmp.iid:F97F117407206811BDDDFD38D0CF24DD 2008-05-16T10:40:59-07:00 Adobe Illustrator CS4 / converted from application/vnd.adobe.illustrator to <unknown> saved xmp.iid:FA7F117407206811BDDDFD38D0CF24DD 2008-05-16T11:26:55-0
Instagram See everyday moments from your close friends . Log into Instagram Mobile number, username or email Password Log in Forgot password? Log in with Facebook Create new account Meta About Blog Jobs Help API Privacy Terms Locations Popular Instagram Lite Meta AI Threads Contact Uploading & Non-Users Meta Verified English Down chevron icon Afrikaans العربية Čeština Dansk Deutsch Ελληνικά English English (UK) Español (España) Español فارسی Suomi Français עברית Bahasa Indonesia Italiano 日本語 한국어 Bahasa Melayu Norsk Nederlands Polski Português (Brasil) Português (Portugal) Русский Svenska ภ
Privacy Policy - Altoida Home About Leadership Science Publications Partnerships Media News Press Releases Our Videos Careers Contact May 12, 2024 Introduction Welcome. You have arrived at a website provided by Altoida, Inc. a Delaware corporation, (“Altoida,” “Company” or “we,” “our” or “us”). This Site is operated by Altoida and has been created to provide information about our Company to our visitors (“you”, “your”). We understand that privacy is important to you and want you to know that we are committed to safeguarding your Personal Information (defined below). This Privacy Policy governs … data, including the time of day you visit our Site. FROM JOB APPLICANTS: If you apply for a job with us by clicking on the link on https://jobs.lever.co/Altoida we may ask you to provide the following information: Your First and Last Name, Email Address, Mailing Address Telephone / mobile number, Employment History, References as necessary to consider your application for open positions. In all instances, your decision to provide us with information is voluntary. If you choos … , including: Responding to requests for information, Evaluating your employment application if you have applied for a position with us, Providing you with updates and information about services we provide, Creating user preferences regarding emails and other correspondence, Improving the effectiveness of our Site, our marketing endeavors, and our product offerings, Helping us address problems with and improve our Site and our products, Protecting the security and integrity of … closures Do Not Track (“DNT”) is a web browser setting that requests that a web application disable its tracking of an individual user. When you choose to turn on the DNT setting in your browser, your browser sends a special signal to websites, analytics companies, ad networks, plug in providers, and other web services you encounter while browsing to stop tracking your activity. Various third parties are developing or have developed signals or other mechanisms for the express … overnment agency). As specified above, to exercise any of these rights, you can submit your request by contacting the Data Subject Access Request (DSAR) Portal or by mail to Altoida, Inc., 80 M Street SE, Suite 100, Washington, DC 20003 – USA We will respond to your privacy requests within 30 days and notify you of the action(s) we have tak
%PDF-1.7 %���� 1 0 obj >/Metadata 7198 0 R/ViewerPreferences 7199 0 R>> endobj 2 0 obj > endobj 3 0 obj >/XObject >/Font >/ProcSet[/PDF/Text/ImageB/ImageC/ImageI] >>/MediaBox[ 0 0 960 540] /Contents 4 0 R/Group >/Tabs/S/StructParents 0>> endobj 4 0 obj > stream x��V�n�@}G� �ZWe��^ߤ(�P�6UZ��P����M��*���egv�� ���,xvv��a�x�nYe�dRA���-� !�R"�8�ke�n}y y�� �0_�[�[gH�� ���v�S���k8;s��� ��л���Q�=ზ > endobj 6 0 obj > stream ����JFIF����C $.' ",# (7),01444 '9=82 ��{���J� V� jF�Rwa�g����:��7� )^ %�J)h����4v�I�EZk��� �K�F}$�4m�eN�ֳ]I�,���H˳Vǂ �(8 … 5\��`vܯ����� �"Tls�qI� z�!�jI������ �=z�li :Kڪo�8L���/�U#�y��n@S����rFp@�Z�[#��ҫ�9M%�����}�A,�NQ�Æ�Y l?ާ}���柴!��K��bG# �)�FNؘ�p:���?�ԃS�c������� �����w.Z��B؊NSz��Gz�MRU�% �,w7m")��{��{6��U|�r��n�㺍�G�̣�H���t�����T�\����(�o��/��)�&�e��?n�%��E#v�y?J�����6*�z���I�rG�^:��#���X�p���I��~-ؘ�,�?����6�]`?��u?�/i�&�5ӝ�XFY�eG�Y�����$��IY R� �+xқ�8[S'8�G5�W�K�ף���Y>��k˾+�� !�a�-# �w �{B" �G%Ƹ/ x��Ŏ.-��4�`y�*� F�j��Y#LD���s��O Io{����]��Wo�\�.��ܞy��� … B_ C6�����K=���wy �W�5����|��Y�Ж�v*# ��w�����i���l$��4��'� �jT�n峈�4כQ�����rFp��I�9,��%JS��o��gk> �������1�G ($����5� i�5�&)g�@w�3kg�0G�9���ut�L���!s�27rr7w��U�m⼷����b���D��l2�g5 һoS�Ti��N���!��� ,�Gsi{��G�~�>�u�OS[: ��]��bLsi��% ���pNy���0�3iz�����R�7���b��G�8���ѵ iZ�6�M�G�s 懒H�ϯj��^&��Q��.��vyo"�=�ϵdx�E����֗+���N�-��H� ? �,�+��rJ��ˁ�0>�ջ�v�D��'�KY9%t�ǒ�3�����V�K�sq ��O ���� ��җX��`$ؐ�ӜF>��� �ܫ�-كB7���T��Dk��i��>\�,�t$$��Tq�{��}�A�����wz� … 4�ywqs���:2Eo��� ֫[B��'0�~�� 5i����>K���,m2A�]����^ }F_4 �v�s@5�b���"8�rFp=�K$_�����$A�=������e|ai�n g�_=uq�{�>O.���fx����;[�h�+��*1ީC��j~;����^H�cp�r �z֧ƻ2�� �d� ��x䐾KsO�| w�k���Ӵ�x���+{�zD�f���]�t��s>���;D��p�8 k��[X5�m�X��*�A��w>�n4�v&+�����xJx�CvT�s��� MDӇ��L��$� �1���Y���&FzsV�H�V����D�D��BwksO�vZ�[�M(��O$��X�zym^~.>]/ ç���i�x�8.4�&����w��SX�&���ͣ w�d ���Y� ��[3��$�cp1�s&��E���WI��� � y=z�y6�n�`�U��}Eri���H M�xZ�8����u�� … pz����aY@�ˌM8�G���,��!�nBppr(@Xm9��0q�-ޚ~Y �P*|� ��� � ֥ӏc����W�9N鴶G��A^:RFp�>�՛�=��R�X�3�5oni|�Ei r��ؗA���6F*�9��� ����n^֖�ލF�,�b��&ӜU�� �ܙ�l���WWٚ�"�L[v��iȪ����Ws�jq�tq � �N��wS\5 ��4���f���%&�M&�ij֝��й��0�������k�9�n�u4G!�/�'������7�}� �/��Q��$&�D��3Qe�U��+X�[ؗW�)4��~e*����� ����.�-��� ��� �5ec�+f�� Y�0��
Portfolio | Hikma Skip to content LSE 1,535.00 GBp About Portfolio Our team Contact Search Close Search the Hikma world Submit Popular searches About Portfolio Our Team Contact Close Open menu Home Portfolio Portfolio Our portfolio Activ Surgical Altibbi Altoida Previous Next Biolinq Click Therapeutics Lemonaid - Acquired by 23andMe Previous Next Nebula Genomics - Acquired by ProPhase Labs Nuvoair O7 Previous Next Pillo - Acquired by Stanley Black & Decker Prognos Propeller - Acquired by ResMed Previous Next SeamlessMD Tact.ai - Acquired by Aktana Winterlight - Acquired by Cambridge Cognit
Sitemap | Hikma Skip to content LSE 1,526.00 GBp Document hub Country sites Back Our international presence Return to Hikma.com Algérie Canada Croatia Egypt France Germany Iraq Italy Jordan KSA Morocco Netherlands Portugal Spain Tunisia UAE UK US Contact Us Who we are Back Who we are Learn more about our purpose, leadership team and commitment to excellence. Who we are Our strategy Our purpose Our culture Leadership Impact History Corporate governance Codes and ethical standards Policy positions and statements What we do Back What we do Learn about our businesses, operations and product p … bs Roles at Hikma Why Hikma News Contact Us Search Close Search the Hikma world Submit Popular searches Investors Careers Products Injectables Contract Close Open menu Home Sitemap Sitemap Home Who we are Our strategy Our purpose Our culture Leadership Victoria Hull Said Darwazah Mazen Darwazah Khalid Nabilsi Douglas Hurt Ali Al-Husry Cynthia Flowers Laura Balan Dr Deneen Vojta Helen Middlemist Hussein Arkhagha Bassam Kanaan Susan Ringdal Hafrun Fridriksdottir Julie Hill Sam … al for Fluphenazine Decanoate Injection Hikma receives Drug Shortage Assistance Award from US FDA Hikma receives FDA approval for Ketamine Hydrochloride Injection Hikma announces launch of Generic Xeloda® Tablets 150 mg and 500 mg in the US Regulatory approval of Hikma’s colchicine is upheld Trading update Trading Update (November 2015) Hikma awarded Best Company in an Emerging Market Hikma launches phentolamine mesylate injection in the US Hikma founder and honora … terim Management Statement Hikma Pharmaceuticals Receives IFC Client Leadership Award Hikma Injectables Analyst and Investor Day Notice - Hikma Injectables Analyst and Investor Day US Hikma Pharmaceuticals Interim Results Notice of Interim Results Announcement 2012 - Analyst Presentation AGM and Interim Management Statement Hikma Pharmaceuticals Preliminary Results Notice for Preliminary Results 2011 Hikma Holds its Annual Training Workshops for Human Resources and Corporate … a Hikma’s Cherry Hill site wins Governor’s Environmental Excellence Award in the US Expanding our onsite renewable energy Generation Inspiring women of Hikma - Meet Judy Bock, Associate Director, Quality Assurance Hikma Pharmaceuticals USA announces $1 Billion of new US investment to further expand its domestic manufacturing and devel
Funding Round - Altoida, Inc. - Skip to content 25th June 2026, Thursday The premier source of the HealthTech World in MENA Section Interviews Profiles Trends & News M&As and Partnerships Events Opinion Reports and Research Infographics Interviews VC Deals Categories BioTech InsurTech Coronavirus Digital Health FemTech FoodTech HealthCare LifeStyle Longevity MedTech Mental Health P4 Medicine Pharma SexTech Stem Cells Technology Startup Life Accelerators & Incubators Diversity and Inclusion Funding and Venture Capital Resources StartUpedia Wellbeing Work Environment Company About us
%PDF-1.4 % ���� 4 0 obj > /PageLabels > ] >> /Outlines 2 0 R /Pages 1 0 R >> endobj 5 0 obj > endobj 6 0 obj > >> endobj 7 0 obj > stream x��W�n7& �x*��oDJk��!�d� �I�@m qׇ�ilrR���}�~ܕvie�lG���,93��o�W������ x�q���5�R��oV�α� ����?�ߊ�~�H �{U�����䜥p�V|4���yE���ɍ�jR�� v'�C�K[oD�3cI��{v���O����P��SHK/Gٛ�nJ�Y�s�1����v�՚���ц� ���� |����4����VڑI #�isz�F��:-ߩn�3Q_M���=���:�Ɗ��3{��I6�ذ�l�bO�WD'��(1��S+�#Lx[T�6��H=S���¤X�X������m�W� ?��?�;��ٻ; � ���,����� $#� �3>��.�lMTQ��Y��{�B��%`����g#����� I�h SO��4Wb1/@c��"�5�(C�^�d�q��m4�Z4IA��+%ZI�~���D�T{j�%�C� … sMt�@���y�Ά 볢� ��%�®�x}Ԑ ���랄�ץj�}�0�C!,��� K�'���ݷ���v@�H� 3|�P�;}8�)}RFp�� �n!OOj鴝fo�E!%U�gm�8��߮h��esuǚ��� ���ǃ�Wn&�ȲG�#o�ͅ���g ��e�d*^���p?:�yr��[�p@?*�x�� � �� ڍ�7 $� �t}~f�>���YW#p���\�&� ��?��T,M�d�q�n��LAtb�d�\v;�`���?ZS ��`6��O9�O~s�¾R�r��pP|�v�:�>�Eʅr���ZL`㠭u�rm�"]�z���%ejV�n�o)�UnU��f�>��l�;9 ��$}� ��A�~�$��&�(�d {���;���D�b6��o�r�1��=�8��P����3g?w���Z� js���Px ���z��$/#�� 7\����U"]���t��MdjҲL�q��z�z;� ����.�~�)E9� ? … � a�T��`�eG�-�#8B�*t S�O �F�0�8�ѱ@�������ٌ�ڟu'˅�@�#���~4E1[r2�*9���( RFp@� ��U��"�,[n�d ��>��1����o+�I�7;}ri�### �}ӏ֧}��2v�?���A4�(*��*N�� � �����s�z/�� ���.��Q��$m ܹ=��=22(�̂@�P��y,� ��s�����~Y� ��*+BNyQ�s� ��4^_����_� �=���>�uoQL���' _S����#(X�g=2ç�?Z����`w`?���9nI?x��o>ݩV?������q���i�� �C���s���Ð�'i�9�{�JDb�9RS$�G>��pH ���u�*D!��� p3��9 �P�+4132��p���u ��� @$3�8��_¢B�n�P r���/L� O�)��L�I$��ۜd ��&�34p�S��ӠC� *���F�,K`�V瞃� … � ��,>�~�2��0��j'4�";�M���t6��#�>��Xs� ��_� O ؠ,��� ��^��+}�|�s3� a���iQ�RfP\���E垀QEQEb�(�,(��)�ȱF�9¨$�juej������ N҇�Mc�xn��e18���+����Y!X�n���=��2d�uA���� ����I��U��\����{Q�l�*�I�t�O�-mJ�t|�8��5�QS*�(́p:`v�eN*�ֲLv2$f��*ݵ��8 Y�+��Ȫ�U�0=�\g�&y��G��F�u� z �;��;�7$����q�O�Y�> R�� ê��T+G���A��m��e���T[ȇ�O���h����,k�+.� ��[Fw�F;.5]���AW&��vZ�1�7�aU��jU'�3P��b��6�=BD�b���^{U���� c�R� ���W�?�Oc �s����I^�-��]���* �y>��A�ƃ�*��`�02 ��l��>g�� … ڈ��tP�\|�M��M.��I� �I�z���Z�����wp�Q�� ���Q@�2�# ��l~ �f�J��`��� ��RFp@�ֺ�(��~���\�����˒B��|�+�-����X�A�QF �%QEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQ
Altoida's predictive Alzheimer's tech assessed in Eisai-collab study | FirstWord HEALTHTECH You need to enable JavaScript to run this app. Loading...
Careers - Altoida Home About Leadership Science Publications Partnerships Media News Press Releases Our Videos Careers Contact Careers Build the Future of Brain Health We’re pioneering a new category in neurology: early, scalable, and objective detection of cognitive disease. To transform brain health diagnostics, we need bold thinkers to get us there. Explore Open Roles Innovation with Impact Grounded in research. Fueled by urgency. Built to solve one of medicine's hardest problems. We're creating what's never existed: early, objective diagnostics built for the front lines of care … nd a collaborative mindset where the best ideas win. Open Roles Department Open Application Even if you don’t see a role that fits your background right now, we’re always looking for passionate, curious, and driven individuals who want to... Clinical Remote View Details Patient Caregiver Family Member Physician Insurance Distribution Partner Investor Other Medical Superintendent Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labor
Frontiers | Sex and gender considerations in Alzheimer’s disease: The Women’s Brain Project contribution Frontiers in Aging Neuroscience About us About us Who we are Mission and values History Leadership Awards Impact and progress Frontiers' impact Our annual reports Thought leadership Publishing model How we publish Open access Quality and research integrity Peer review Research Topics Publish your data Fee policy Services Societies National consortia Institutional partnerships Collaborators More from Frontiers Frontiers Forum Frontiers Planet Prize Press office Sustainability Career oppo … office Sustainability Career opportunities Contact us All journals All articles Submit your research Search Frontiers in Aging Neuroscience Sections Sections Aging Neuroscience Archive Alzheimer's Disease and Related Dementias Cellular and Molecular Mechanisms of Brain-aging Neurocognitive Aging and Behavior Neuroinflammation and Neuropathy Parkinson’s Disease and Aging-related Movement Disorders Articles Research Topics Editorial board About journal About journal Scope F … rnal sections Open access statement Copyright statement Quality For authors Why submit? Article types Author guidelines Editor guidelines Publishing fees Submission checklist Contact editorial office About us About us Who we are Mission and values History Leadership Awards Impact and progress Frontiers' impact Our annual reports Thought leadership Publishing model How we publish Open access Quality and research integrity Peer review Research Topics Publish your data Fee p … partnerships Collaborators More from Frontiers Frontiers Forum Frontiers Planet Prize Press office Sustainability Career opportunities Contact us All journals All articles Submit your research Frontiers in Aging Neuroscience Sections Sections Aging Neuroscience Archive Alzheimer's Disease and Related Dementias Cellular and Molecular Mechanisms of Brain-aging Neurocognitive Aging and Behavior Neuroinflammation and Neuropathy Parkinson’s Disease and Aging-related Movement D … rnal sections Open access statement Copyright statement Quality For authors Why submit? Article types Author guidelines Editor guidelines Publishing fees Submission checklist Contact editorial office Frontiers in Aging Neuroscience Sections Sections Aging Neuroscience Archive Alzheimer's Disease and Related Dementias Cellular and Molecular Me
Altoida upsizes its Series A Round to $20.3M to Advance NEWS INTERVIEWS AiThority Text Interviews Podcast – AI Inspired Stories INSIGHTS GUEST AUTHORS AIT STAFF WRITER AI RADAR A Analytics Automation Apps AIT Featured Posts Augmented Reality AIT MegaMind Autonomous Vehicles AI Machine Learning Projects AiThority.com Primers Assistive Technologies Arguments Against AI B Blockchain Big Data Business Intelligence Bots/Intelligent Assistants C Cloud Computing Cryptocurrency Customer Experience Chatbots & Intelligent Assistants ChatGPT Computer Vision Challenges customer Experience Conten
Drug giant Allergan is... - Racing to End Alzheimer's Facebook Log In Racing to End Alzheimer's Post Racing to End Alzheimer's September 8, 2017 · Shared with Public Drug giant Allergan is partnering with Boston based startup, Lyndra, to develop a once-weekly drug to combat Alzheimer’s. "Replacing multiple daily pills with one weekly pill will ease the burden of medication compliance and simplify the day-to-day challenges of chronic conditions" says CEO Amy Schulman. Lyndra’s innovative sustained-release technology has the potential to improve patient health outcomes a
Patients Ask: Does Early Menopause Cause Dementia? - Altoida Home About Leadership Science Publications Partnerships Media News Press Releases Our Videos Careers Contact Patients Ask: Does Early Menopause Cause Dementia? July 26, 2022 | adminalt According to new preliminary research, women who experience early menopause are more likely to develop dementia later in life. For women nearing the menopause transition, this has raised the question of whether or not early menopause can cause dementia. In this article, we will discuss the relationship between early menopause and dementia risk, t
Central Nervous System Collaboration and Licensing Deals 2020-2026 Your browser is not supported. To avoid security issues and to comply with web standards, please upgrade to a modern browser. ABOUT US CONTACT US FAQ  USD EUR GBP USD ▼ USD EUR GBP € EUR $ USD £ GBP +353-1-416-8900 REST OF WORLD +44-20-3973-8888 REST OF WORLD 1-917-300-0470 EAST COAST U.S 1-800-526-8630 U.S. (TOLL FREE)  Login / Register Contact Us About Us View Categories Our Services Our Services Back Market Research Custom Research Conferences & Training Subscriptio … utics Barrow Neurological Institute Base4 Biotechnology Baszucki Brain Research Fund Battelle Beacon Biosignals Beam Therapeutics Beijing InnoCare Pharma Belay Diagnostics Belharra Therapeutics BenevolentAI Benuvia Therapeutics Be The Match BioTherapies Beth Israel Deaconess Medical Center Bexorg Bexson Biomedical Bial BigHat Biosciences BioArctic AB biOasis Technologies BioAxone BioSciences Biobeat Biocept BioCircuit Technologies Biocodex Biocytogen BioDelivery Sciences Biof … rvice CRADA Cross-licensing Development Distribution Equity purchase Evaluation Grant Joint venture Licensing Loan Manufacturing Marketing Option Promotion Research Royalty financing Settlement Spin out Sub license Supply Termination Warrant Every deal record is fully categorized and includes the following data, where available: Industry sector Therapy areas Technology type Deal components Financial terms Stage of development Exclusivity Asset type Geographic focus Excluded g … ation and Licensing Deals 2020-2026 close close ASK A QUESTION RESERVE MY PLACE Submit the form to confirm your enrolment and receive payment instructions. An error occurred while sending the message. Should this issue persist, email us at [email protected] * Required Information Name * Mr Mrs Dr Miss Ms Prof { }..." data-val-regex-pattern="^[^<>{}]*$" data-val-required="First Name field is required!" id="ProductEnquiry_FirstName" maxlength="50" name="ProductEnqu
Altoida, Inc. | Alzheimer's Drug Discovery Foundation Donate Email Sign Up Search Search Submit Twitter Facebook YouTube Linkedin About Us Our Founders Staff Leadership Young Professionals Committee Our Impact Our Partners Annual Reports & Financials Careers Alzheimer's Disease What is Alzheimer's? Alzheimer's Causes Diagnosis & Treatment Alzheimer's Prevention Patient & Family Resources Research Our Research Strategy Funding Opportunities COVID-19 FAQ Diagnostics Accelerator SpeechDx Goodes Prize Our Portfolio Portfolio Highlights Reporting For Funded Projects ADDF Reports Events & Confer … Conditions Privacy Policy Close DONATE SIGN UP Twitter Facebook YouTube Search* Submit About Us Our Founders Staff Leadership Young Professionals Committee Our Impact Our Partners Annual Reports & Financials Careers Alzheimer's Disease What is Alzheimer's? Alzheimer's Causes Diagnosis & Treatment Alzheimer's Prevention Patient & Family Resources Research Our Research Strategy Funding Opportunities Diagnostics Accelerator Melvin R. Goodes Prize
Altoida - Open Application Open Application Remote Clinical / Contract / Remote apply for this job Even if you don’t see a role that fits your background right now, we’re always looking for passionate, curious, and driven individuals who want to help transform how brain health is assessed. Who You Are You’re excited by innovation at the intersection of neuroscience, technology, and healthcare. You thrive in a fast-paced, collaborative environment and aren’t afraid to take initiative. You’re motivated by impact—building something that can change the trajectory of disease. Potential Areas of Int … responses and identifying potential inconsistencies or verification signals in application materials based on available information. These tools assist our recruitment team but do not replace human judgment. Final hiring decisions are ultimately made by humans. If you would like more information about how your data is processed, please contact us. apply for this job Altoida Home Page Jobs powered by
Head of Regulatory Affairs & Quality - Altoida | Built In Companies Jobs Articles Can't find your company? Create a company profile. View All Jobs Join Log In For Employers Altoida Jobs Head of Regulatory Affairs & Quality Altoida Head of Regulatory Affairs & Quality Sorry, this job was removed at 08:18 p.m. (CST) on Wednesday, Jun 04, 2025 Be an Early Applicant Hiring Remotely in USA Remote Healthtech The Role Altoida is defining a new category in neurological care with a first-of-its-kind, multi-modal platform built to unlock access to clinical-grade cognitive and functional diagnost … e), and manage responses to regulatory queries and inspection non- conformance. Apply a least burdensome regulatory approach while ensuring appropriate design, manufacturing, distribution, and commercial controls to support innovation and business growth. Interpret and communicate regulatory expectations to internal and external stakeholders, including partners, supply chain, CROs, consultants, and contractors, to ensure program objectives align with applicable regulations. P … • Cloud • Security • Software • Cybersecurity Easy Apply Remote or Hybrid 5 Locations 6500 Employees 195K-286K Annually Dynatrace Sr Director, Customer Education Portfolio Artificial Intelligence • Big Data • Cloud • Information Technology • Software • Big Data Analytics • Automation Remote or Hybrid Boston, MA, USA 5600 Employees Collectors Senior Software Engineer Consumer Web • eCommerce • … w Altoida Profile Report Job Continue Not Eligible Save You are not eligible to apply because your location does not meet the criteria for this role. Apply Instructions Sign up now Access later Create Free Account Already have an account? Log In Please log in or sign up to report this job. Create Free Account Already have an account? Log In Companies Jobs Tracker Articles More Join Log In Tech Jobs Companies Articles Remote Best Places To Work Tech Hubs Post Job © 2026 Built
Altoida Board Boost: Ignite Neuro Sales Pipeline NewsletterForLeads.com Search Sign Up Now Open main menu Sign Up Now Home Posts Altoida Board Boost: Ignite Your Neuro Sales Pipeline Altoida Board Boost: Ignite Your Neuro Sales Pipeline Altoida adds AI & pharma heavyweights to its board. Use this sales trigger to turbocharge your deal flow, plan your next touch, and close more neuro tech commissions. Published on Jun 24, 2026 Do not index Do not index 🚀 Battle Card: Altoida Quick trigger: 👤 Decision Maker in the News Mona Flores, MD , Clinical and Scientific Advisory Board Member · 🔗 [L
Altoida Expands Advisory Board with Global Leaders in AI, Pharma, and Alzheimer’s Patient Advocacy to Accelerate the Advancement of its Category-Defining Digital Brain Health Platform - Altoida Home About Leadership Science Publications Partnerships Media News Press Releases Our Videos Careers Contact Altoida Expands Advisory Board with Global Leaders in AI, Pharma, and Alzheimer’s Patient Advocacy to Accelerate the Advancement of its Category-Defining Digital Brain Health Platform October 8, 2025 | Jenna Hanson New appointments strengthen Altoida’s position as the inevitable standard fo
Earlier Detection of Cognitive… - Health Connective Show - Apple Podcasts Search Home New Top Charts Search September 16, 2025 33 min Earlier Detection of Cognitive Disorders with Marc Jones of Altoida Health Connective Show Play Marc Jones, CEO of Altoida, joins our hosts to talk about their NeuroMarker platform and its potential to detect cognitive disorders like Alzheimer’s in earlier stages. Learn how earlier detection enables more effective treatment, and how Altoida is working to change the current standard of care for Alzheimer’s. Hosted on Acast. See acast.com/privacy for more informat
Altoida's Digital NeuroMarker Platform: A Breakthrough in Alzheimer's Care | Marc Jones posted on the topic | LinkedIn LinkedIn respects your privacy LinkedIn and 3rd parties use essential and non-essential cookies to provide, secure, analyze and improve our Services, and to show you relevant ads (including professional and job ads ) on and off LinkedIn. Learn more in our Cookie Policy . Select Accept to consent or Reject to decline non-essential cookies for this use. You can update your choices at any time in your settings . Accept Reject Agree & Join LinkedIn By clicking Continue to
Altoida Announces Global Experts in Neuroscience Join its Scientific Advisory Board to Advance Innovation in Cognitive Health Diagnostics - Altoida Home About Leadership Science Publications Partnerships Media News Press Releases Our Videos Careers Contact Altoida Announces Global Experts in Neuroscience Join its Scientific Advisory Board to Advance Innovation in Cognitive Health Diagnostics October 15, 2024 | Jenna Hanson Leading pioneers in neuroscience, cognitive health, and digital biomarkers join Altoida’s mission to transform early Alzheimer's detection and care Altoida , a leader … the Department of Medicine at a community hospital. He completed his neurology residency and fellowship at Vanderbilt, holds a medical degree from the University of Mississippi, a master’s degree in clinical investigation from Vanderbilt University, and a B.S. in Chemistry from Mississippi State University. John Harrison, Ph.D, a recognized cognition expert dedicated to helping people understand, maintain, and enhance their cognitive abilities. He is the Chief Scientific Off
Explore Altoida’s 2025 Research on Alzheimer's Diagnosis - Altoida Home About Leadership Science Publications Partnerships Media News Press Releases Our Videos Careers Contact Explore Altoida’s 2025 Research on Alzheimer's Diagnosis December 10, 2025 | Jenna Hanson Explore Altoida’s latest research advancing the early detection and precision diagnosis of Alzheimer’s disease and related neurodegenerative conditions. Presented at leading global conferences in 2025, these publications and posters highlight how multi-modal digital biomarkers powered by augmented reality and AI can deliv
Digital biomarkers: Redefining clinical outcomes and the concept of meaningful change Digital biomarkers: Redefining clinical outcomes and the concept of meaningful change Alzheimers Dement (N Y) . 2025 Jun 2;11(2):e70114. doi: 10.1002/trc2.70114. eCollection 2025 Apr-Jun. Authors Maria Florencia Iulita 1 , Emmanuel Streel 1 , John Harrison 2 Affiliations 1 Altoida Inc. Washington District of Columbia USA. 2 Scottish Brain Sciences Gyleview House South Gyle Edinburgh UK. PMID: 40463636 PMCID: PMC12130567 DOI: 10.1002/trc2.70114 Abstract MCID (minimal clinically … entify as important. There are several challenges associated with the universal application of this construct. Alzheimer's disease progresses differently for each individual, complicating the establishment of a universal standard that accounts for individual-level issues. Alzheimer's disease is also a gradual and evolving disorder, and what is perceived as clinically meaningful can vary significantly at early and late disease stages. People living with Alzheimer's disease and
Scientific Advisory Board - Altoida Home About Leadership Science Publications Partnerships Media News Press Releases Our Videos Careers Contact Meet Our Scientific Advisory Board Mike Edgeworth, MD, FAAN Chief Medical Officer, Nira Medical Marc Jones Executive Chairman and Chief Executive Officer Marc is the Chief Executive Officer at Altoida. He is a healthcare technology business leader with more than 25 years of experience across both private and publicly-held companies. Prior to Altoida, Marc served as the Chief Operating Officer (COO) and Chief Financial Officer (CFO) of binx health, a d
Informative piece in Nature Digital Medicine on how digital cognitive assessments are setting a new standard for objective, scalable, and real-time measures of brain health that support proactive… | Marc Jones LinkedIn respects your privacy LinkedIn and 3rd parties use essential and non-essential cookies to provide, secure, analyze and improve our Services, and to show you relevant ads (including professional and job ads ) on and off LinkedIn. Learn more in our Cookie Policy . Select Accept to consent or Reject to decline non-essential cookies for this use. You can update your choices at any t
Our Leadership Team | Altoida Home About Leadership Science Publications Partnerships Media News Press Releases Our Videos Careers Contact Meet Our Leadership Team Our multi-disciplinary team of scientists, entrepreneurs, and technologists have united to create the future of precision neurology diagnostics. We are dedicated to building a next-generation digital biomarkers platform that could revolutionize the field. Through the power of our proprietary machine-learning and augmented-reality technology, we are developing a precision neurology platform intended to redefine the industry standard.
Building Your Cognitive Reserve: Insights from Our CSO Home About Leadership Science Publications Partnerships Media News Press Releases Our Videos Careers Contact Building Your Cognitive Reserve: Insights from Our CSO Over the past decade, an increasing number of studies have reported cases of older individuals with extensive Alzheimer’s disease pathology (e.g., beta-amyloid plaques) during brain autopsy, yet during late life, the cognition of these individuals remained intact. So, why is this? The answer to this question lies in the concepts of neural reserve and cognitive reserve. Neural re … nd Dartmouth College USA. His awards and distinctions include the EU Archimedes award for Natural User Interfaces for medical devices, the European Open Science Forum (ESOF) award for his symposium on “virtual reality technologies for cognition” and the Novartis AG fellowship on healthy aging. In 2018, he received the prestigious EIT Innovators award for the Alzheimer's Disease Prediction Service (ADPS). To learn more about building your cognitive reserve, or about using Alto
Building something ambitious takes more than vision—it takes belief, partnership, and grit. I’m grateful to be surrounded by investors who bring all three. Thank you to Arnd Kaltofen-Ehmann and the… | Marc Jones LinkedIn respects your privacy LinkedIn and 3rd parties use essential and non-essential cookies to provide, secure, analyze and improve our Services, and to show you relevant ads (including professional and job ads ) on and off LinkedIn. Learn more in our Cookie Policy . Select Accept to consent or Reject to decline non-essential cookies for this use. You can update your choices at any
Annual Report 2023 Table of Contents 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 Annual Report 2023 Annual Report 2023 Table of Contents 2023 – A Year of Change 5 Horizon Europe and Switzerland: Review of 2023 6 The Euresearch Network 7 Activity Report of NCPs and Regional Offices 8 Activity Report of NCPs and Regional Offices: 2023 Figures 12 Strategic Activities 14 Financial Report 16 Euresearch Offices 24 The Association 25 5 Euresearch Annual Report 2023 2023 – A Year of Change The year 2023 was tempestuous on a global scale. The ongoing conflicts at the edge o … he Euresearch Network made further steps towards getting fit for the future. By rolling out the Microsoft Teams application, the whole Network is now constantly connected, has easy access to the latest information and can efficiently share knowledge. This transition was accompanied by an expert group and an array of training sessions, for which we are very grateful. Nevertheless, the transition entailed some time and effort for all employees. In 2021, the pandemic had forced … ave continuously decreased. In 2023, those clients that are already planning to submit (applicants) made up the biggest client segment (36%). Our service types are grouped into “inform”, “advise”, and “connect”. The overall stable circumstances, together with the national package of Transitional Measures, may explain the shift towards more individually tailored advisory services and away from informational services aimed at groups. The “connect” service remained the least use … ted as it gives participants the possibility to network and to talk about their fellowship and about living and working in Zurich. 9 Euresearch Annual Report 2023 In October, the “European Funding – Companies & Academic Collaborations” event took place at the Y-Parc Swiss Technopole in Yverdon-lesBains. The event was organised by Euresearch Regional Offices at the HES-SO and EPFL (company advisors) in collaboration with Innosuisse and Y-Parc. 45 people participated in the … rm 43% Connect 2% Advise 55% 2022 1.4 Top Five Services 2023 Project Advice 24% Proposal Advice 21% Proposalrelated Information 9% Opportunity Posting 5% Other Services 23% Information on EU RDI Opportunities 18% 2022 Prospects 44% 13 Euresearch Annual Report 2023 5. Newsletter 6. Social Media LinkedIn Followers 2022: 4275 2023: 5094 +19.2% YouTu
Tietosuojavalintasi guce guce Tietosuojasi on meille tärkeää Tietosuojavalintojasi käytetään kaikissa Yahoo-konsernin tarjoamissa sivustoissa ja sovelluksissa. Yahoo käyttää evästekäytännöstämme ."> Evästeet Evästeiden (sekä vastaavien tekniikoiden, esimerkiksi verkkotallennuksen) avulla verkkosivustojen sovellusten ylläpitäjät voivat tallentaa ja lukea laitteesi tietoja. Lue lisää evästekäytännöstämme . evästeitä seuraaviin tarkoituksiin: tarjotaksemme sivustomme ja sovelluksemme sinulle todentaaksemme käyttäjät, estääksemme roskapostia ja väärinkäytöksiä sekä toteuttaaksemme tietoturvatoimia
Bold early investments in... - Alzheimer's Association Facebook Log In Alzheimer's Association's Post Alzheimer's Association Verified account March 13 · Shared with Public Bold early investments in science are helping change the future of Alzheimer’s research. Breakthroughs in Alzheimer’s research often begin with early investments in science. Over the past 14 years, the Part the Cloud movement — founded by philanthropist Michaela “Mikey” Hoag in partnership with the Association — has invested more than $84 million in 83 clinical trials across 12 countries, helping acceler … e event honored Princess Yasmin Aga Khan with the inaugural Part the Cloud Icon Award and featured a powerful message from caregiver and advocate Emma Heming Willis. During the luncheon, the Alzheimer’s Association and Part the Cloud also announced the next bold step: a $30 million initiative by 2028 to accelerate the next generation of Alzheimer’s research, including combination therapies, early translational studies and emerging AI-driven discoveries. Supporters raised more
Our Science - Altoida Home About Leadership Science Publications Partnerships Media News Press Releases Our Videos Careers Contact Developing Digital Biomarkers for Neurological Disease Powered by Machine Learning Altoida is developing first-of-kind, digital neurological biomarkers designed to assess cognition in clinical trials. The platform will involve a tablet-based application that uses augmented reality (AR) to replicate activities of daily living (iADLs) measuring cognitive and motoric functions via multimodal digital biomarkers. The motoric and AR tasks in the Altoida assessment are de … amyloid pathology, as an adjunct to other diagnostic evaluations, and plans to submit a request for marketing authorization to FDA for these or similar indications. Our platform is currently intended for investigational use only. The platform has not received FDA clearance or approval and is not available for commercial sale. Why Altoida was created Symptoms of Alzheimer’s disease appear when the condition is already too advanced for clinical management. For years, det
Tietosuojavalintasi guce guce Tietosuojasi on meille tärkeää Tietosuojavalintojasi käytetään kaikissa Yahoo-konsernin tarjoamissa sivustoissa ja sovelluksissa. Yahoo käyttää evästekäytännöstämme ."> Evästeet Evästeiden (sekä vastaavien tekniikoiden, esimerkiksi verkkotallennuksen) avulla verkkosivustojen sovellusten ylläpitäjät voivat tallentaa ja lukea laitteesi tietoja. Lue lisää evästekäytännöstämme . evästeitä seuraaviin tarkoituksiin: tarjotaksemme sivustomme ja sovelluksemme sinulle todentaaksemme käyttäjät, estääksemme roskapostia ja väärinkäytöksiä sekä toteuttaaksemme tietoturvatoimia
Advisory Board - Altoida Home About Leadership Science Publications Partnerships Media News Press Releases Our Videos Careers Contact Meet Our Advisory Board Mike Edgeworth, MD, FAAN Chief Medical Officer, Nira Medical Marc Jones Executive Chairman and Chief Executive Officer Marc is the Chief Executive Officer at Altoida. He is a healthcare technology business leader with more than 25 years of experience across both private and publicly-held companies. Prior to Altoida, Marc served as the Chief Operating Officer (COO) and Chief Financial Officer (CFO) of binx health, a digital health and mole
Checking your browser - reCAPTCHA Checking your browser before accessing pmc.ncbi.nlm.nih.gov ... Click here if you are not automatically redirected after 5 seconds.
Altoida Appoints Marc Jones as Chief Executive Officer - Altoida Home About Leadership Science Publications Partnerships Media News Press Releases Our Videos Careers Contact Altoida Appoints Marc Jones as Chief Executive Officer June 5, 2023 | adminalt WASHINGTON--( BUSINESS WIRE )-- Altoida, Inc , a pioneer in developing digital biomarkers of neurological disease using augmented reality and machine learning, announced today the appointment of industry veteran Marc Jones as Chief Executive Officer. Jones will also serve on the company’s Board. "We are thrilled that Marc is joining Altoid
Altoida Chief Science Officer Ioannis Tarnanas to Keynote at Worldwebforum Accessibility Statement Skip Navigation Resources Investor Relations Journalists +44 (0)20 7454 5110 Client Login Send a Release News Products Contact Search Search When typing in this field, a list of search results will appear and be automatically updated as you type. Searching for your content... No results found. Please change your search terms and try again. News in Focus Browse News Releases All Public Company News All Multimedia News View All News Releases Regulatory News D/A/CH Regulatory News UK Regulatory News … ces Blog Journalists Data Privacy Do not sell or share my personal information: Submit via [email protected] Call Privacy toll-free: 877-297-8921 Contact PR Newswire Products About My Services All News Releases Customer Portal Resources Blog Journalists +44 (0)20 7454 5110 from 8 AM - 5:30 PM GMT Terms of Use Privacy Policy Information Security Policy Site Map RSS Cookie Settings Copyright © 2025 PR Newswire Europe Limited. All Rights Reserved. A Cision company. --> --
Atlantic Fellows | Ioannis Tarnanas Community Community Community Overview The Community Who Are Atlantic Fellows? Published Work Meet our Founder The legacy of Chuck Feeney Meet our Fellows Fellows directory Explore by Country Countries Index Our Programs Find a country Equity in Brain Health Health Equity Global Health Equity in South Africa Health Equity in Southeast Asia Racial Equity Social and Economic Equity Social Equity Explore Programs Equity in Brain Health Racial Equity Social Equity Health Equity Global Health Equity in South Africa Social and Economic Equity Health Equity in Sout … ty Health Equity in Southeast Asia Atlantic Institute Explore Programs Atlantic Fellowship Programs Explore all programs Impact Impact Impact Overview Impact Center Fellows in Action Media Mentions Published Works Impact Stories Brain health across borders: global art-based approach to COVID-19 psychosocial impacts A new automated and integrated epidemiological information system A new, creative lens to focus on brain health Strengthening epidemic preparedness in Nigeria HoSA … ive impact. Follow us Contact Us Our Core The Atlantic Institute Seven Atlantic Fellowship Programs The Atlantic Institute Partner with the Atlantic Institute The Atlantic Institute Team Atlantic Institute Governing Board Global Atlantic Fellows Advisory Board Find A Contact Looking for a program contact? Our Directory XR Gallery Get Involved Home Fellows Ioannis Tarnanas Ioannis Tarnanas United States Equity in Brain Health Co-founder, Altoida, Inc. Bio Heading Lorem ipsum d … ide: Reimagining health, healing and humanity at the Emerging Technology Health Residency April 29, 2025 Why equity requires reparations for Africans and people of African descent: Reflections on the African Union’s theme of the year March 27, 2025 Climate Action and Power: The Purse Strings of Influence March 13, 2025 A purposeful visit to Oxford by Atlantic Fellows Fernando Peres, Maureen Sigauke and Michelle Steele February 21, 2025 Swallowed by Water: XR storytelling for … social care: building relationships, diversity and action November 30, 2023 XR residency: binding beyond the physical present November 22, 2023 Speaking to the stomach: communicating beyond hearts and minds to achieve change November 23, 2023 São Paulo, a place of hope, political vibrancy and an inspiration for us all November 22, 2023 Freeing t
Ioannis Tarnanas – Worldwebforum Skip to content Worldwebforum 8th Annual Meeting About Membership What’s on Log in Home About Membership What’s on He developed Altoida Neuro Motor Index app which measures brain health & fights dementia Ioannis Tarnanas Chief Science Officer, Altoida, Zurich, Switzerland Digital Health Track Speaker Why you should listen Oftentimes, symptoms for Alzheimer’s disease appear when the condition is already too late to cure. For years, detection is gathered from blunt and unreliable tools such as a relative of a patient observing that the latte … a. Ioannis created Altoida, the world’s first validated solution and iPad-based application to enter the market as a pre-symptomatic, computational biomarker that predicts the risk of Alzheimer’s Disease. His company, Altoida Inc, provides health care professionals the “Neuro Motor Index” application which can detect early & subtle micro-errors (accuracy) and micro-movements (latency) during everyday function, up to 6 years prior to the onset of typical neurod … anas has received many awards and distinctions. Those include the EU Archimedes award in 2001 for developing and testing Natural User Interfaces for medical devices, which would be compatible with cognitively impaired seniors, the 2006 European Open Science Forum (ESOF) award for his symposium on “virtual reality technologies for rehabilitation” and the Novartis AG award/fellowship on healthy aging in 2014 for his project, utilizing a variety of elegant techniques including a
Alzheimer's Diagnostics - ADDF 2023 Annual Report Annual Report 2023 Annual Report 2023 Home Therapeutics Diagnostics Prevention Home Therapeutics Diagnostics Prevention Download Report SHARE Share This Page (X formerly Twitter) Facebook Linkedin Download Report DIAGNOSTICS The Path Toward Effective Treatments Starts With An Early And Accurate Diagnosis ADDF-Funded Screening Tool Facilitates Milestone Drug Approval ADDF-supported diagnostics are already making a notable impact, improving clinical trial designs and serving as the driving force behind recent breakthroughs. The Amyvid PET sc … reliable, affordable, and accessible diagnostic… Many [Diagnostics Accelerator] award recipients are already making terrific progress.” Bill Gates, Inaugural Funder of the Diagnostics Accelerator Progress in Groundbreaking Biomarkers Using Artificial Intelligence to Detect Dementia Ioannis Tarnanas, PhD Using Artificial Intelligence to Detect Dementia Altoida, led by Co-Founder and Chief Scientific Officer Ioannis Tarnanas, PhD, is developing a digital system for early Alzhei
Head of Regulatory Affairs & Quality @ Altoida, Inc. | FYRFLY Venture Partners Job Board About Portfolio Careers Pledge 1% Contact Us Careers Search jobs Explore companies Join talent network Talent My job alerts Head of Regulatory Affairs & Quality Altoida, Inc. This job is no longer accepting applications See open jobs at Altoida, Inc. . See open jobs similar to " Head of Regulatory Affairs & Quality " FYRFLY Venture Partners . Legal, Quality Assurance Remote Posted 6+ months ago Altoida is defining a new category in neurological care with a first-of-its-kind, multi-mod … e), and manage responses to regulatory queries and inspection non- conformance. Apply a least burdensome regulatory approach while ensuring appropriate design, manufacturing, distribution, and commercial controls to support innovation and business growth. Interpret and communicate regulatory expectations to internal and external stakeholders, including partners, supply chain, CROs, consultants, and contractors, to ensure program objectives align with applicable regulations. P
Altoida Leaders Discuss AI in Early Cognitive Decline Detection | Cameron McLauchlin posted on the topic | LinkedIn LinkedIn respects your privacy LinkedIn and 3rd parties use essential and non-essential cookies to provide, secure, analyze and improve our Services, and to show you relevant ads (including professional and job ads ) on and off LinkedIn. Learn more in our Cookie Policy . Select Accept to consent or Reject to decline non-essential cookies for this use. You can update your choices at any time in your settings . Accept Reject Agree & Join LinkedIn By clicking Continue to join or sig
#growth #comfortzone #reflection #growth #yearinreview #newchapter #2025goals | Maggie Rougier-Chapman | 28 comments LinkedIn respects your privacy LinkedIn and 3rd parties use essential and non-essential cookies to provide, secure, analyze and improve our Services, and to show you relevant ads (including professional and job ads ) on and off LinkedIn. Learn more in our Cookie Policy . Select Accept to consent or Reject to decline non-essential cookies for this use. You can update your choices at any time in your settings . Accept Reject Agree & Join LinkedIn By clicking Continue to join or si … more than a term sheet. Our job is to amplify the efforts of founders, not just fund them. That means rolling up our sleeves to bring: - Domain expertise (especially in deep tech, AI, and digital health), - Warm introductions to pharma, payors, and regulators, - Access to top-tier academic and clinical partners in Switzerland and beyond, - Strategic guidance as companies move from science to scalable commercial models. We’ve had the privilege of supporting Altoida through thi
News - M Ventures Zum Inhalt springen Wegweiser About Us Portfolio Team Career News Contact Zur Startseite wechseln News Find out more about us and our portfolio companies Filter by year: All years 2026 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 All years All years 2026 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2026/06/19 LabGenius Therapeutics and LG Chem Enter a Research Collaboration, Option and License Agreement to Develop an AI/ML-Designed Tumour-Targeting Antibody The companies have entered into a multi-year research collaboration, option and licensing agreement … apeutics in Neurodegenerative Diseases 2024/06/29 Metalenz wins AI Breakthrough Award for Best Overall Biometrics Solution 2024/06/20 Celestial AI's $175M Series C Highlighted in Crunchbase News 2024/06/20 iOnctura announces EUR80 million Series B financing to progress pipeline through Phase II trials 2024/06/19 Quintessent CEO Alan Liu on Photonic Chip Technology 2024/06/16 Celestial AI: One Of The 10 Hottest Semiconductor Startups Of 2024 2024/05/21 LabGenius raises £3 … Dang Pharm Licenses Synaffix ADC Technology 2023/02/03 Metalenz Wins 2023 Prism Award 2023/02/02 Purple Biotech acquires Immunorizon and Its Portfolio of Tri-Specific Antibodies 2023/01/25 Rewind Therapeutics Adds Sunstone Life Science Ventures A/S as New Investor 2023/01/25 STORM Therapeutics Presents STC-15 Preclinical Data 2023/01/10 STORM Therapeutics Expands R&D Leadership Team 2023/01/05 iOnctura Provides Development Update on PI3Kδ Inhibitor 2023/01/05 Synaffix Ent … herapeutics announces closing of USD $30M Series B financing 2022/12/13 Another Award for Synaffix: ‘Business Development Team of Year’ at the Scrip Awards 2022/12/08 IOnctura Initiates Phase Ib Pancreatic Cancer Trial Of Next-Generation Autotaxin Inhibitor IOA-289 2022/11/30 Electroninks Partners with Citrine Informatics to Develop Enhanced Silver Ink Using AI-Assisted R&D 2022/11/16 Synaffix Named ‘Biotech Company of the Year’ at the LSX European Lifestars Awards 2022/1 … ces 2022/06/08 Scipio bioscience selected for €2.5M European Innovation Council grant 2022/05/31 Altoida Appoints Neuroscience Pioneer Dr. Antontella Santuccione Chadha as Chief Medical Officer 2022/05/31 Theolytics' £1M project with InnovateUK to develop a novel therapy for multiple myeloma patients 2022/05/04 Asceneuron Awarded Second Gran